Document And Entity Information
Document And Entity Information - USD ($) | 12 Months Ended | ||
Dec. 31, 2022 | Mar. 30, 2023 | Jun. 30, 2022 | |
Document Information [Line Items] | |||
Entity Central Index Key | 0001447380 | ||
Entity Registrant Name | MOBIVITY HOLDINGS CORP. | ||
Amendment Flag | false | ||
Current Fiscal Year End Date | --12-31 | ||
Document Fiscal Period Focus | FY | ||
Document Fiscal Year Focus | 2022 | ||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Period End Date | Dec. 31, 2022 | ||
Document Transition Report | false | ||
Entity File Number | 000-53851 | ||
Entity Incorporation, State or Country Code | NV | ||
Entity Tax Identification Number | 26-3439095 | ||
Entity Address, Address Line One | 3133 West Frye Road, # 215 | ||
Entity Address, City or Town | Chandler | ||
Entity Address, State or Province | AZ | ||
Entity Address, Postal Zip Code | 85226 | ||
City Area Code | 877 | ||
Local Phone Number | 282-7660 | ||
Title of 12(g) Security | Common Stock, $.001 par value | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 70,218,462 | ||
Entity Common Stock, Shares Outstanding | 65,607,411 | ||
Auditor Name | M&K CPAS, PLLC | ||
Auditor Firm ID | 2738 | ||
Auditor Location | Houston, TX |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) | Dec. 31, 2022 | Dec. 31, 2021 |
Current assets | ||
Cash | $ 426,740 | $ 735,424 |
Accounts receivable, net of allowance for doubtful accounts of $34,446 and $56,340, respectively | 1,081,183 | 578,303 |
Other current assets | 195,017 | 227,458 |
Total current assets | 1,702,940 | 1,541,185 |
Goodwill | 0 | 411,183 |
Right to use lease assets | 981,896 | 1,187,537 |
Intangible assets and software development costs, net | 194,772 | 1,124,720 |
Other assets | 137,917 | 173,325 |
TOTAL ASSETS | 3,017,525 | 4,437,950 |
Current liabilities | ||
Accounts payable | 3,412,612 | 3,823,909 |
Accrued interest | 443,448 | 172,239 |
Accrued and deferred personnel compensation | 569,347 | 495,533 |
Deferred revenue and customer deposits | 902,727 | 377,170 |
Related party notes payable, net - current maturities | 2,711,171 | 819,531 |
Notes payable, net - current maturities | 32,617 | 69,052 |
Operating lease liability, current | 251,665 | 229,240 |
Other current liabilities | 49,541 | 9,071 |
Total current liabilities | 8,373,128 | 5,995,745 |
Non-current liabilities | ||
Related party notes payable, net - long-term | 2,481,290 | 2,498,711 |
Notes payable, net - long-term | 31,092 | 39,086 |
Operating lease liability, noncurrent | 936,924 | 1,188,589 |
Total non-current liabilities | 3,449,306 | 3,726,386 |
Total liabilities | 11,822,434 | 9,722,131 |
Commitments and Contingencies (See Note 13) | ||
Stockholders' equity (deficit) | ||
Common stock, $0.001 par value; 100,000,000 shares authorized; 61,311,155 and 55,410,695, shares issued and outstanding | 61,311 | 55,411 |
Equity payable | 324,799 | 100,862 |
Additional paid-in capital | 108,806,353 | 102,446,921 |
Accumulated other comprehensive income (loss) | (100,963) | (52,088) |
Accumulated deficit | (117,896,409) | (107,835,287) |
Total stockholders' equity (deficit) | (8,804,909) | (5,284,181) |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | $ 3,017,525 | $ 4,437,950 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parentheticals) - USD ($) | Dec. 31, 2022 | Dec. 31, 2021 |
Accounts receivable, allowance for doubtful accounts | $ 34,446 | $ 56,340 |
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized (in shares) | 100,000,000 | 100,000,000 |
Common stock, shares issued (in shares) | 61,311,155 | 55,410,695 |
Common stock, shares outstanding (in shares) | 61,311,115 | 55,410,695 |
Consolidated Statements of Oper
Consolidated Statements of Operations and Comprehensive Loss - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Revenues | ||
Revenues | $ 7,533,912 | $ 8,174,884 |
Cost of revenues | 5,328,483 | 4,302,370 |
Gross profit | 2,205,429 | 3,872,514 |
Operating expenses | ||
Bad Debt | 40,383 | 774,312 |
General and administrative | 4,306,929 | 3,584,721 |
Sales and marketing | 2,616,596 | 4,002,565 |
Engineering, research, and development | 3,060,029 | 3,583,773 |
Goodwill Impairment | 411,183 | 85,169 |
Intangible asset impairment | 552,476 | 8,286 |
Depreciation and amortization | 440,326 | 707,073 |
Total operating expenses | 11,427,922 | 12,745,899 |
Loss from operations | (9,222,493) | (8,873,385) |
Other income/(expense) | ||
Interest income | 0 | 5 |
Gain on Extinguishment of Debt | 0 | 891,103 |
Interest expense | (737,745) | (267,966) |
Loss on disposal of fixed assets | 0 | (880) |
Settlement Losses | (53,500) | |
Loss on settlement of debt | (49,503) | 0 |
Foreign currency gain (loss) | 2,119 | (8,661) |
Total other income (expense) | (838,629) | 613,601 |
Loss before income taxes | (10,061,122) | (8,259,784) |
Income tax expense | 0 | 0 |
Net Loss | (10,061,122) | (8,259,784) |
Other comprehensive income (loss), net of income tax | ||
Foreign currency translation adjustments | (48,875) | (28,642) |
Comprehensive loss | $ (10,109,997) | $ (8,288,426) |
Net loss per share: | ||
Basic and Diluted (in dollars per share) | $ (0.17) | $ (0.15) |
Weighted average number of shares: | ||
Basic and Diluted (in shares) | 59,241,798 | 55,410,695 |
Consolidated Statement of Stock
Consolidated Statement of Stockholders' Equity (Deficit) - USD ($) | Common Stock [Member] | Equity Payable [Member] | Additional Paid-in Capital [Member] | AOCI Attributable to Parent [Member] | Retained Earnings [Member] | Total |
Balance (in shares) at Dec. 31, 2020 | 55,410,695 | |||||
Balance at Dec. 31, 2020 | $ 55,411 | $ 100,862 | $ 101,186,889 | $ (23,446) | $ (99,575,503) | $ 1,744,213 |
Issuance of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Fair value of options issued with related party debt | 0 | 0 | 262,758 | 0 | 0 | 262,758 |
Stock based compensation | 0 | 0 | 997,274 | 0 | 0 | 997,274 |
Foreign currency translation adjustments | 0 | 0 | 0 | (28,642) | 0 | (28,642) |
Net loss | $ 0 | 0 | 0 | 0 | (8,259,784) | (8,259,784) |
Balance (in shares) at Dec. 31, 2021 | 55,410,695 | |||||
Balance at Dec. 31, 2021 | $ 55,411 | 100,862 | 102,446,921 | (52,088) | (107,835,287) | (5,284,181) |
Issuance of common stock | 2,562 | 2,047,438 | 2,050,000 | |||
Fair value of options issued with related party debt | 0 | 0 | 143,039 | 0 | 0 | 143,039 |
Stock based compensation | 0 | 0 | 1,457,570 | 0 | 0 | 1,457,570 |
Foreign currency translation adjustments | 0 | 0 | 0 | (48,875) | 0 | (48,875) |
Net loss | $ 0 | 0 | 0 | 0 | (10,061,122) | (10,061,122) |
Issuance of common stock for warrants exercised (in shares) | 3,188,190 | |||||
Issuance of common stock for warrants exercised | $ 3,188 | 0 | 2,547,364 | 0 | 0 | 2,550,552 |
Issuance of common stock (in shares) | 2,562,500 | |||||
Issuance of common stock for debt settlement (in shares) | 149,770 | |||||
Issuance of common stock for debt settlement | $ 150 | 223,937 | 164,021 | 388,108 | ||
Balance (in shares) at Dec. 31, 2022 | 61,311,155 | |||||
Balance at Dec. 31, 2022 | $ 61,311 | $ 324,799 | $ 108,806,353 | $ (100,963) | $ (117,896,409) | $ (8,804,909) |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
OPERATING ACTIVITIES | ||
Net loss | $ (10,061,122) | $ (8,259,784) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Bad Debt | 40,383 | 774,312 |
Loss on settlement of debt -Related Party | 49,503 | 0 |
Gain on Extinguishment of Debt | 0 | (891,103) |
Stock-based compensation | 1,457,570 | 997,274 |
Loss on disposal of fixed assets | 0 | 880 |
Intangible asset impairment | 552,476 | 8,286 |
Goodwill Impairment | 411,183 | 85,169 |
Depreciation and amortization expense | 440,326 | 707,073 |
Amortization of debt discount | 122,258 | 31,000 |
Increase (decrease) in cash resulting from changes in: | ||
Accounts receivable | (543,263) | (365,213) |
Other current assets | 32,102 | 40,133 |
Operating lease assets/liabilities | (23,599) | (2,575) |
Contracts receivable, long-term | 0 | 707,928 |
Other assets | (31) | 2,330 |
Accounts payable | (411,297) | 1,888,498 |
Accrued interest | 609,814 | 168,673 |
Accrued and deferred personnel compensation | (79,283) | 270,590 |
Accrued Professional Fees | 148,402 | 0 |
Other liabilities - non-current | 0 | (415,766) |
Other liabilities - current | 40,470 | (2,876) |
Deferred revenue and customer deposits | 525,557 | (229,427) |
Net cash used in operating activities | (6,688,551) | (4,484,598) |
INVESTING ACTIVITIES | ||
Purchases of equipment | (17,182) | (79,219) |
Cash paid for patents | 0 | 0 |
Capitalized software development costs | (13,087) | (299,253) |
Net cash used in investing activities | (30,269) | (378,472) |
FINANCING ACTIVITIES | ||
Payments on notes payable | (39,142) | (561,528) |
Payments on related party notes payable | 0 | (280,000) |
Proceeds from related party notes payable | 1,895,000 | 3,206,250 |
Proceeds from conversion of common stock warrants | 2,550,552 | 0 |
Proceeds from PIPE funding | 2,050,000 | 0 |
Net cash provided by financing activities | 6,456,410 | 2,364,722 |
Effect of foreign currency translation on cash flow | (46,274) | (49,048) |
Net change in cash | (308,684) | (2,547,396) |
Cash at beginning of period | 735,424 | 3,282,820 |
Cash at end of period | 426,740 | 735,424 |
Supplemental disclosures: | ||
Interest | 0 | 68,389 |
Non cash investing and financing activities: | ||
Fair Value of options Issued with related party debt | 143,039 | 0 |
Debt Discount on Related Party Debt | 262,658 | 262,658 |
Fixed Assets contribution by lessor | 0 | 110,000 |
Refinancing of debt-related party | 0 | 43,750 |
Initial ROU and asset lease liabiltiy | 0 | 1,458,527 |
Shares Issued for settlement of debt - related party | $ 338,605 | $ 0 |
Note 1 - Nature of Operations
Note 1 - Nature of Operations | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Nature of Operations [Text Block] | 1. Mobivity Holdings Corp. (the “Company” or “we”) is in the business of developing and operating proprietary platforms over which brands and enterprises can conduct national and localized, data-driven marketing campaigns. Mobivity’s Recurrency platform enables multi-unit retailers to leverage the power of their own data to yield maximum customer spend, frequency and loyalty while achieving the highest Return on Marketing Spend (ROMS) possible. Mobivity’s customers use Recurrency to: ● Transform messy point-of-sale (POS) data collected from thousands of points of sale into usable intelligence. ● Measure, predict, and boost guest frequency and spend by channel. ● Deploy and manage one ● Deliver 1:1 Mobivity’s Recurrency, delivered as a SaaS platform, is used by leading brands including Subway, Sonic Drive-In, Chick-fil-A, Checkers/Rally’s and Circle K’s across more than 40,000 retail locations globally. We’re living in a data-driven economy. In fact, by 2003 two 2003. 90% two one The challenge for multi-unit retailers isn’t that they don’t have enough data; in fact, national retailers are collecting millions of detailed transactions daily from thousands of points of sale around the world. The challenge is being able to make sense of this transaction data, which is riddled with data entry errors, collected by multiple POS systems and complicated by a taxonomy compiled by thousands of different franchisee owners. To normalize such an overwhelming amount of data into usable intelligence and then leverage it to optimize media investment and promotion strategy requires numerous teams of data analysts and data scientists that many retailers and restaurant operators simply don’t have. Which is why so many technology and data companies, that can help solve these challenges, have been invested in and acquired by brands including, McDonald’s, Starbucks and Yum Brands. Mobivity’s Recurrency platform fills this need with a self-service SaaS offering, enabling operators to intelligently optimize their promotions, media and marketing spend. Recurrency drives system-wide sales producing on average a 13% increase in guest spend and a 26% improvement in frequency, ultimately delivering an average Return on Marketing Spend of 10X. ten incremental We generate revenue by charging the resellers, brands and enterprises a per-message transactional fee, or through fixed or variable software licensing fees. |
Note 2 - Summary of Significant
Note 2 - Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Significant Accounting Policies [Text Block] | 2. Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, LiveLenz Inc. All significant intercompany balances and transactions have been eliminated. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates used are those related to stock-based compensation, asset impairments, the valuation and useful lives of depreciable tangible and certain intangible assets, the fair value of common stock used in acquisitions of businesses, the fair value of assets and liabilities acquired in acquisitions of businesses, the fair value of options issued with related party debt, and the valuation allowance of deferred tax assets. Management believes that these estimates are reasonable; however, actual results may Reclassifications Certain prior year amounts have been reclassified to conform to the current year’s presentation. The reclassifications had no Acquisitions We account for acquired businesses using the purchase method of accounting. Under the purchase method, our consolidated financial statements reflect the operations of an acquired business starting from the completion of the acquisition. In addition, the assets acquired and liabilities assumed are recorded at the date of acquisition at their respective estimated fair values, with any excess of the purchase price over the estimated fair values of the net assets acquired recorded as goodwill. Cash and Cash Equivalents We minimize our credit risk associated with cash by periodically evaluating the credit quality of our primary financial institution. Our balances at times may not Accounts Receivable, Allowance for Doubtful Accounts and Concentrations Accounts receivable are carried at their estimated collectible amounts. We grant unsecured credit to substantially all of our customers. Ongoing credit evaluations are performed, and potential credit losses are charged to operations at the time the account receivable is estimated to be uncollectible. Since we cannot necessarily predict future changes in the financial stability of our customers, we cannot guarantee that our reserves will continue to be adequate. As of December 31, 2022 2021 From time to time, we may one As of December 31, 2022 four December 31, 2021 three Goodwill and Intangible Assets Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first not not may We conducted our annual impairment tests of goodwill as of December 31, 2022 2021 December 31, 2022 2021, Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, and non-compete agreements. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from one twenty No may not The Company’s evaluation of its long-lived assets resulted in $552,476 and $8,286 of intangible impairment expense during the years ended December 31, 2022 December 31, 2021 Software Development Costs Software development costs include direct costs incurred for internally developed products and payments made to independent software developers and/or contract engineers. The Company accounts for software development costs in accordance with the FASB guidance for the costs of computer software to be sold, leased, or otherwise marketed (“ASC Subtopic 985 20” not not Capitalized costs for those products that are cancelled or abandoned are charged to impairment expense in the period of cancellation. Commencing upon product release, capitalized software development costs are amortized to “Amortization Expense - Development” based on the straight-line method over a twenty-four The Company evaluates the future recoverability of capitalized software development costs on an annual basis. For products that have been released in prior years, the primary evaluation criterion is ongoing relations with the customer. The Company’s evaluation of its capitalized software development asset resulted in impairment charges of $0 for the year ended December 31, 2022 December 31, 2021 Impairment of Long-Lived Assets We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not Foreign Currency Translation The Company translates the financial statements of its foreign subsidiary from the local (functional) currency into US Dollars using the year or reporting period end or average exchange rates in accordance with the requirements of Accounting Standards Codification subtopic 830 10, 830 10” Derivative Financial Instruments We do not We review the terms of the common stock, warrants and convertible debt we issue to determine whether there are embedded derivative instruments, including embedded conversion options, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one Revenue Recognition and Concentrations Our Recurrency platform is a hosted solution. We generate revenue from licensing our software to clients in our software as a service model, per-message and per-minute transactional fees, and customized professional services. We recognize license/subscription fees over the period of the contract, service fees as the services are performed, and per-message or per-minute transaction revenue when the transaction takes place. Under Topic 606, no During the years ended December 31, 2022 2021 two Comprehensive Income (Loss) Comprehensive loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We are required to record all components of comprehensive loss in the consolidated financial statements in the period in which they are recognized. Net loss and other comprehensive loss, including foreign currency translation adjustments and unrealized gains and losses on investments, are reported, net of their related tax effect, to arrive at comprehensive loss. For the twelve December 31, 2022 2021 $10,109,997,and Stock-based Compensation We primarily issue stock-based awards to employees in the form of stock options. We determine compensation expense associated with stock options based on the estimated grant date fair value method using the Black-Scholes valuation model. We recognize compensation expense using a straight-line amortization method over the respective vesting period. Research and Development Expenditures Research and development expenditures are expensed as incurred, and consist primarily of compensation costs, outside services, and expensed materials. Advertising Expense Direct advertising costs are expensed as incurred and consist primarily of E-commerce advertisements, sales enablement, content creation, and other direct costs. Advertising expense was $377,201 and $962,049 for years ended December 31, 2022 2021 December 31, 2022 2021 Income Taxes We account for income taxes using the assets and liability method, which recognizes deferred tax assets and liabilities determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established to reduce deferred tax assets when, based on available objective evidence, it is more likely than not not not Computation of Net Loss per Common Share Basic net loss per share is based upon the weighted average number of common shares outstanding. Diluted net loss per share is based on the assumption that all potential common stock equivalents (convertible notes payable, stock options, and warrants) are converted or exercised. The calculation of diluted net loss per share excludes potential common stock equivalents if the effect is anti-dilutive. Our weighted average common shares outstanding for basic and diluted are the same because the effect of the potential common stock equivalents is anti-dilutive. We had the following dilutive common stock equivalents as of December 31, 2022 2021 December 31, 2022 2021 Outstanding employee options 6,691,216 6,246,466 Outstanding restricted stock units 1,929,933 1,685,141 Outstanding warrants 6,147,898 3,246,690 14,769,047 11,178,297 Recent Accounting Pronouncements Accounting standards promulgated by the FASB are subject to change. Changes in such standards may In August 2020, 2020 06, 2020 06” No. 2020 06 January 1, 2022. |
Note 3 - Going Concern
Note 3 - Going Concern | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Substantial Doubt about Going Concern [Text Block] | 3. We have $426,740 of cash as of December 31, 2022 2022 February 2022 2022. first 2023. 12 no not 12 As shown in the accompanying financial statements, the Company has incurred net losses from operations resulting in an accumulated deficit of $117,896,409 as of December 31, 2022 twelve not |
Note 4 - Goodwill and Intangibl
Note 4 - Goodwill and Intangible Assets | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Goodwill and Intangible Assets Disclosure [Text Block] | 4. Goodwill and Intangible Assets Goodwill The following table presents goodwill and impairment for the years ended December 31, 2022 2021 Goodwill December 31, 2020 $ 496,352 Acquired — Impairment (85,169 ) December 31, 2021 411,183 Acquired — Impairment (411,183 ) December 31, 2022 $ — We conducted our annual impairment test of goodwill as of December 31, 2022 2021 Intangible assets The following table presents components of identifiable intangible assets for the years ended December 31, 2022 2021 December 31, 2022 December 31, 2021 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Useful Life (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Useful Life (Years) Patents and trademarks $ 57,595 $ (4,897 ) $ 52,698 14 $ 105,543 $ (47,948 ) $ 57,595 14 Customer and merchant relationships 545,533 (514,843 ) 30,690 10 2,321,112 (1,775,579 ) 545,533 10 Trade name 32,393 (24,343 ) 8,050 10 197,955 (165,562 ) 32,393 10 Acquired technology 112,191 (112,191 ) — 10 621,030 (508,839 ) 112,191 10 Non-compete agreement 29,212 (29,212 ) — 2 79,300 (50,088 ) 29,212 2 $ 776,924 $ (685,486 ) $ 91,438 $ 3,324,940 $ (2,548,016 ) $ 776,924 During the years ended December 31, 2022 2021 During the years ended December 31, 2022 2021 Expected future intangible asset amortization as of December 31, 2022 Year ending December 31, Amount 2022 $ 35,885 2023 12,639 2024 4,891 2025 4,891 2025 4,891 Thereafter 28,241 Total $ 91,438 |
Note 5 - Software Development C
Note 5 - Software Development Costs | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Research, Development, and Computer Software Disclosure [Text Block] | 5. Software Development Costs The Company has capitalized certain costs for software developed or obtained for internal use during the application development stage as it relates to specific contracts. The amounts capitalized include external direct costs of services used in developing internal-use software and for payroll and payroll-related costs of employees directly associated with the development activities. The balance is included in the net intangible assets on the balance sheet. The following table presents details of our software development costs for the years ended December 31, 2022 2021 December 31, 2022 December 31, 2021 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Useful Life (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Useful Life (Years) $ 2,578,611 $ (2,475,277 ) $ 103,334 2 $ 2,565,525 $ (2,217,729 ) $ 347,796 2 $ 2,578,611 $ (2,475,277 ) $ 103,334 $ 2,565,525 $ (2,217,729 ) $ 347,796 Software development costs are being amortized on a straight-line basis over their estimated useful life of two During the years ended December 31, 2022 2021 During the years ended December 31, 2022 2021 The estimated future amortization expense of software development costs as of December 31, 2022 Year ending December 31, Amount 2023 98,828 2024 4,506 2025 — 2026 — 2027 — Thereafter — Total $ 103,334 |
Note 6 - Operating Lease Assets
Note 6 - Operating Lease Assets | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Lessee, Operating Leases [Text Block] | 6. Operating Lease Assets Adoption of Accounting Standards Codification ( ASC ) Topic 842, Leases." 842 January 1, 2019, January 1, 2019, 842, not The following are additional details related to leases recorded on our balance sheet as of December 31, 2021 Leases Classification Balance at December 31, 2022 Assets Current Operating lease assets Operating lease assets $ — Noncurrent Operating lease assets Noncurrent operating lease assets 981,896 Total lease assets $ 981,896 Liabilities Current Operating lease liabilities Operating lease liabilities $ 251,665 Noncurrent Operating lease liabilities Noncurrent operating lease liabilities $ 936,924 Total lease liabilities $ 1,188,589 During the year ended December 31, 2022 December 31, 2021 Rent expense was $371,213 and $258,368 for the years ended December 31, 2022 2021 We entered into our current lease starting in February 2021 3133 215, first twelve 50% 842. The maturity analysis below summarizes the remaining future undiscounted cash flows for our operating leases, a reconciliation to operating lease liabilities reported on the Condensed Consolidated Balance Sheet, our weighted-average remaining lease term and weighted average discount rate: Year ending December 31, Amount 2023 $ 324,221 2024 330,894 2025 337,568 2026 344,241 2027 28,733 Thereafter — Total future lease payments 1,365,657 Less: imputed interest (177,068 ) Total $ 1,188,589 Weighted Average Remaining Lease Term (years) Operating leases 4.08 Weighted Average Discount Rate Operating leases 6.75 % |
Note 7 - Notes Payable and Inte
Note 7 - Notes Payable and Interest Expense | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Debt Disclosure [Text Block] | 7. Notes Payable and Related Party Notes Payable The following table presents details of our notes payable as of December 31, 2022 2021 Facility Maturity Interest Rate December 31, 2022 December 31, 2021 ACOA Note February 1, 2024 — 34,231 76,642 TD Bank December 31, 2022 — 29,478 31,496 Related Party Notes various 15 % 5,192,461 3,318,242 Total Debt 5,256,170 3,426,380 Less current portion (2,743,788 ) (888,583 ) Long-term debt, net of current portion $ 2,512,382 $ 2,537,797 Principal payments on notes payables are due as follows: Year ending December 31, Amount 2023 $ 2,743,788 2024 2,497,643 2025 14,739 2026 — 2027 — Thereafter — Total future debt payments 5,256,170 ACOA Note On November 6, 2017, December 2, 2014 June 1, 2016, February 1, 2024. November 1, 2019, August 1, 2021, August 1, 2022 twelve December 31, 2021 19. During the twelve December 31, 2022 Wintrust Loan On November 14, 2018, three first six May 1, 2019, On August 7, 2020, March 31, 2020 June 30, 2020 no twelve December 31, 2021 June 30, 2021. Chase Loan On April 10, 2020, two one six no may July 21, 2021, TD Bank Loan On April 22, 2020, December 31, 2022. zero no December 31, 2023. thirty-three sixty-seven Related Party Notes Secured Promissory Notes On June 30, 2021, one November 11, 2022. December 31, 2021, 2020 The Credit Facility is secured by all of our tangible and intangible assets including intellectual property. This loan bears interest on the unpaid balance at the rate of fifteen may twenty three Under the original terms of the Credit Agreement, the Company was to begin repaying the principal amount, plus accrued interest, in 24 equal monthly installments commencing on June 30, 2022, June 30, 2024. November 11, 2022, 2.3 24 January 31, 2023 not fifteen 365 July 1, 2022, December 31, 2022, On June 10, 2022, On August 09, 2022 On November 22, 2022 On November 30, 2022 On December 27, 2022 During the year ended December 31, 2022 December 31,2022. As of December 31, 2022, $44,325. Unsecured Promissory Note On July 1, 2021, fifteen no December 31, 2023. may two On August 13, 2022, January 31, 2022, July 1, 2022 December 31, 2022 As of December 31, 2022, $10,423 Interest Expense The following table summarizes interest expense for the years ended December 31, 2022 2021 December 31, 2022 2021 Interest expense $ 737,745 $ 267,966 Total interest expense $ 737,745 $ 267,966 |
Note 8 - Common Stock and Equit
Note 8 - Common Stock and Equity Payable | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Common Stock and Equity Payable | 8. Common Stock and Equity Payable Common Stock 2022 On December 31, 2022 $260,010 As of December 31, 2022 $324,799. During the year ended December 31, 2022 5,900,460 $260,010 $0 2021 During the year ended December 31, 2021 not As of December 31, 2022 |
Note 9 - Stock-based Plans and
Note 9 - Stock-based Plans and Stock-based Compensation | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Stockholders' Equity Note Disclosure [Text Block] | 9. Stock-based Plans and Stock-based Compensation Stock-based Plans We have the 2010 2013 2016 2022 December 31, 2022 We believe that such awards better align the interests of our directors, officers and employees with those of our shareholders. Option awards are generally granted with an exercise price that equals the fair market value of our stock at the date of grant. These option awards generally vest based on four The following table summarizes stock option activity under our stock-based plans as of and for the years ended December 31, 2022 2021 Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding at December 31, 2020 6,007,552 $ 1.20 6.77 $ 527,868 Granted 637,500 $ 1.56 — $ — Exercised — $ 1.61 — $ — Forfeit/canceled (272,029 ) $ 2.18 — $ — Expired (126,557 ) $ 1.17 — $ — Outstanding at December 31, 2021 6,246,466 $ 1.20 7.17 $ 4,056,639 Granted 1,375,000 $ 1.02 — $ — Exercised — $ — — $ — Forfeit/canceled (330,623 ) $ 1.09 — $ — Expired (599,627 ) $ 0.98 — $ — Outstanding at December 31, 2022 6,691,216 $ 1.19 5.86 $ 2,086,829 Expected to vest at December 31, 2022 6,691,216 $ 1.19 5.85 $ 2,086,829 Exercisable at December 31, 2022 3,987,966 $ 1.22 3.98 $ 1,314,652 Unrecognized expense at December 31, 2022 $ 1,698,126 The aggregate intrinsic value of options was calculated as the difference between the exercise price of the underlying awards and the quoted price of our common stock. At December 31, 2022 The weighted average grant-date fair value of options granted during the years 2022 2021 2021 On March 26, 2021, five March 26, 2021, forty-eight March 26, 2031. On May 17, 2021, one May 17, 2021, forty-eight January 21, 2031. On August 11, 2021, one August 11, 2021, forty-eight August 11, 2031. On December 15, 2021, nineteen December 15, 2021, forty-eight February 18, 2029. $.97 In the twelve December 31, 2021 2022 On March 29, 2022, March 29, 2022, first March 29, 2032. On May 16, 2022, May 16, 2022, first May 16, 2032. On September 22, 2022, September 2022, first September 29, 2032. On December 14, 2022, December 14, 2022, first September 29, 2032. In the twelve December 31, 2022, In the twelve December 31, 2022 $260,010 Stock-based Compensation Expense The impact on our results of operations of recording stock-based compensation expense for the years ended December 31, 2022 2021 Years Ended December 31, 2022 2021 General and administrative $ 262,060 $ 289,782 Sales and marketing 113,838 81,093 Engineering, research, and development 211,712 178,893 $ 587,610 $ 549,768 As of December 31, 2022 2022 2026. may Stock Option Valuation Assumptions We calculated the fair value of each stock option award on the date of grant using the Black-Scholes option pricing model. The ranges of assumptions were used for the years ended December 31, 2022 2021 Years Ended December 31, 2022 2021 Risk-free interest rate 0.25% to 0.38% 0.42% to 0.58% Expected life (years) 7.00 6.00 Expected dividend yield — — Expected volatility 72.337% to 76.15% 77.36% to 78.21% The risk-free interest rate assumption is based upon published interest rates appropriate for the expected life of our employee stock options. The expected life of the stock options represents the weighted-average period that the stock options are expected to remain outstanding and was determined based on historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards, vesting schedules and expectations of future employee behavior as influenced by changes to the terms of its stock-based awards. The dividend yield assumption is based on our history of not no The expected volatility in 2022 2021 Restricted stock units The following table summarizes restricted stock unit activity under our stock-based plans as of and for the years ended December 31, 2022 2021 Shares Weighted Average Grant Date Fair Value Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding at December 31, 2020 1,436,728 $ 0.86 — $ 1,120,404 Awarded 654,663 $ 1.77 — $ 60,003 Released — $ — — $ — Canceled/forfeited/expired (406,250 ) $ 1.80 — $ — Outstanding at December 31, 2021 1,685,141 $ 1.18 — $ 1,180,407 Awarded 244,792 $ 1.06 — $ 260,579 Released — $ — — $ — Canceled/forfeited/expired — $ — — $ — Outstanding at December 31, 2022 1,929,933 $ 0.75 — $ 1,440,986 Vested at December 31, 2022 1,929,933 $ — — $ 1,865,401 Unvested at December 31, 2022 — $ — — $ — Unrecognized expense at December 31, 2022 $ — 2021 On March 26, 2021 1/48 th four 2022 On March 26, 2021 four first 2021. March 26, 2024, On May 12, 2021, four May 12, 2024, ( On August 11, 2021, four August 11, 2024, On December 15, 2021, four December 15, 2024, In the twelve December 31, 2021 2022 On March 29, 2022, March 29, 2025, On May 16, 2022, May 16, 2025 ( On September 30, 2022, $.9985 September 30, 2025 ( On December 31, 2022 December 31, 2025, In the twelve December 31, 2022 Restricted Stock Unit Compensation Expense The impact on our results of operations of recording stock-based compensation expense for years ended December 31, 2022 2021 Years Ended December 31, 2022 2021 General and administrative $ 260,010 $ 260,005 Sales and Marketing — 187,501 $ 260,010 $ 447,506 |
Note 10 - Warrants to Purchase
Note 10 - Warrants to Purchase Common Stock | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Warrants To Purchase Common Stock Disclosure [Text Block] | 10. Warrants to Purchase Common Stock The following table summarizes investor warrant activity as of and for the years ended December 31, 2022 2021 Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Outstanding at December 31, 2020 2,691,459 $ 1.99 2.94 Granted 580,231 $ — — Exercised — $ — — Canceled/forfeited/expired (25,000 ) $ — — Outstanding at December 31, 2021 3,246,690 $ 2.26 3.59 Granted 6,089,398 $ — — Exercised — $ — — Canceled/forfeited/expired (3,188,190 ) $ — — Outstanding at December 31, 2022 6,147,898 $ 1.45 2.27 We did record stock-based compensation expense of $609,950 December 31, 2022 2021 Warrants Exercised in 2021 On June 30, 2021, On August 11, 2021, 30 As of September 30, 2021, 2023. 2024. Warrants Exercised in 2022 On February 9, 2022, three February 2025. February 9, 2022. On June 29, 2022, six three June 2025, On August 24, 2022, five three August 2025, |
Note 11 - Income Taxes
Note 11 - Income Taxes | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Income Tax Disclosure [Text Block] | 11. Income Taxes On March 27, 2020, 19 2017 2017 1 2019 2020; 2 3 4 5 not For the years ended December 31, 2022 2021 2022 2021 Federal – current $ — $ — State – current — — Foreign – current — — Total $ — $ — Under ASC 740, Significant components of our net deferred tax assets and liabilities as of December 31, 2022 2021 2022 2021 Deferred tax assets (liabilities): Net operating loss carryforwards $ 19,791,000 $ 16,915,000 Stock based compensation 4,781,000 4,372,000 Accrued compensation 231,300 31,000 Depreciation and amortization 3,305,000 3,783,000 Other — 2,000 Total deferred tax assets 28,108,300 25,103,000 Valuation allowance for net deferred tax assets (28,108,300 ) (25,103,000 ) Total $ — $ — The Company has provided a valuation allowance against deferred tax assets recorded as of December 31, 2022 2021 The net change in the total valuation allowance for the year ended December 31, 2022 December 31, 2021 not not not not no As of December 31, 2022 2026. 2028. The difference between the provision for income taxes and income taxes computed using the U.S. federal income tax rate for the years ended December 31, 2022 2021 2022 2021 Computed expected tax expense $ (2,088,000 ) $ (1,735,000 ) State taxes, net of federal benefit (1,030,000 ) (799,000 ) Expiration of NOL carryforwards (684,000 ) 87,000 Other 101,000 142,000 Change in valuation allowance 3,701,000 1,729,000 Total $ ---- $ The Company has determined that during 2010 382 2010 2010 not 382, 2010, 382. may The Company files income tax returns in the U.S. federal jurisdiction, Arizona, and California. Because the Company is carrying forward federal and state net operating losses from 2006, 2006. not December 31, 2022 |
Note 12 - Fair Value Measuremen
Note 12 - Fair Value Measurements of Financial Instruments | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Fair Value Disclosures [Text Block] | 12. Fair Value Measurements of Financial Instruments The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2022 Description Level 1 Level 2 Level 3 Gains (Losses) Goodwill (non-recurring) $ — $ — $ — $ — Intangibles, net (non-recurring) $ — $ — $ 194,772 $ — The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2021 Description Level 1 Level 2 Level 3 Gains (Losses) Goodwill (non-recurring) $ — $ — $ 411,183 $ — Intangibles, net (non-recurring) $ — $ — $ 1,124,720 $ — The Company recorded goodwill, intangible assets and an earn-out payable as a result its business combinations, and these assets were valued with the assistance of a valuation consultant and consisted of Level 3 The Company’s financial instruments consist of cash, accounts receivable, accounts payable, and accrued liabilities. The estimated fair value of cash, accounts receivable, accounts payable and accrued liabilities approximate their carrying amounts due to the short-term nature of these instruments. None |
Note 13 - Commitments and Conti
Note 13 - Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Commitments and Contingencies Disclosure [Text Block] | 13. Commitments and Contingencies Litigation As of the date of this report, the company has one §501.059 one not not No During the year ending December 31, 2022 three Operating Lease The Company had a lease through January 2021 55 310, December 31, 2022, 842. We have entered into a new lease starting in February 2021 3133 215, first twelve December 31, 2022 842. The Company also had a lease through April 2022 December 31, 2022 842. |
Note 14 - Employee Benefit Plan
Note 14 - Employee Benefit Plan | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Compensation and Employee Benefit Plans [Text Block] | 14. Employee Benefit Plan The Company has an employee savings plan (the “Plan”) pursuant to Section 401 may not may December 31, 2022 2021 |
Note 15 - Related Party Transac
Note 15 - Related Party Transactions | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Related Party Transactions Disclosure [Text Block] | 15. Related Party Transactions Related Party Notes Secured Promissory Notes On June 30, 2021, one November 11, 2022. December 31, 2021, 2020 The Credit Facility is secured by all of our tangible and intangible assets including intellectual property. This loan bears interest on the unpaid balance at the rate of fifteen may twenty three Under the original terms of the Credit Agreement, the Company was to begin repaying the principal amount, plus accrued interest, in 24 equal monthly installments commencing on June 30, 2022, June 30, 2024. November 11, 2022, 2.3 24 January 31, 2023 not fifteen 365 July 1, 2022, December 31, 2022, On June 10, 2022, On August 09, 2022 On November 22, 2022 On November 30, 2022 On December 27, 2022 During the year ended December 31, 2022 December 31,2022. As of December 31, 2022, $44,325 Unsecured Promissory Note On July 1, 2021, fifteen no December 31, 2023. may two On August 13, 2022, January 31, 2022, July 1, 2022 December 31, 2022 As of December 31, 2022, $10,423 Related Party Warrant Exercise On February 7, 2022, $1.283,518. three February 2025. On February 7, 2022, three February 2025. Related Party Private Placement On August 24, 2022, three August 2025. |
Note 16 - Subsequent Events
Note 16 - Subsequent Events | 12 Months Ended |
Dec. 31, 2022 | |
Notes to Financial Statements | |
Subsequent Events [Text Block] | 16. Subsequent Events 2023 During the quarter ended March 30, 2023, 15 three February 2025. 2023 On January 31, 2023, No. 1 November 11, 2022, December 1, 2025. January 1, 2024 December 1, 2025, ninety 90 The foregoing description of the Amendment does not 8 January 31, 2023, 10.1 8 2023 On January 31, 2023 On March 27, 2023 On March 27, 2023 |
Significant Accounting Policies
Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Consolidation, Policy [Policy Text Block] | Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, LiveLenz Inc. All significant intercompany balances and transactions have been eliminated. |
Use of Estimates, Policy [Policy Text Block] | Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates used are those related to stock-based compensation, asset impairments, the valuation and useful lives of depreciable tangible and certain intangible assets, the fair value of common stock used in acquisitions of businesses, the fair value of assets and liabilities acquired in acquisitions of businesses, the fair value of options issued with related party debt, and the valuation allowance of deferred tax assets. Management believes that these estimates are reasonable; however, actual results may |
Reclassification, Comparability Adjustment [Policy Text Block] | Reclassifications Certain prior year amounts have been reclassified to conform to the current year’s presentation. The reclassifications had no |
Business Combinations and Other Purchase of Business Transactions, Policy [Policy Text Block] | Acquisitions We account for acquired businesses using the purchase method of accounting. Under the purchase method, our consolidated financial statements reflect the operations of an acquired business starting from the completion of the acquisition. In addition, the assets acquired and liabilities assumed are recorded at the date of acquisition at their respective estimated fair values, with any excess of the purchase price over the estimated fair values of the net assets acquired recorded as goodwill. |
Cash and Cash Equivalents, Policy [Policy Text Block] | Cash and Cash Equivalents We minimize our credit risk associated with cash by periodically evaluating the credit quality of our primary financial institution. Our balances at times may not |
Receivable [Policy Text Block] | Accounts Receivable, Allowance for Doubtful Accounts and Concentrations Accounts receivable are carried at their estimated collectible amounts. We grant unsecured credit to substantially all of our customers. Ongoing credit evaluations are performed, and potential credit losses are charged to operations at the time the account receivable is estimated to be uncollectible. Since we cannot necessarily predict future changes in the financial stability of our customers, we cannot guarantee that our reserves will continue to be adequate. As of December 31, 2022 2021 From time to time, we may one As of December 31, 2022 four December 31, 2021 three |
Goodwill and Intangible Assets, Policy [Policy Text Block] | Goodwill and Intangible Assets Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first not not may We conducted our annual impairment tests of goodwill as of December 31, 2022 2021 December 31, 2022 2021, Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, and non-compete agreements. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from one twenty No may not The Company’s evaluation of its long-lived assets resulted in $552,476 and $8,286 of intangible impairment expense during the years ended December 31, 2022 December 31, 2021 |
Internal Use Software, Policy [Policy Text Block] | Software Development Costs Software development costs include direct costs incurred for internally developed products and payments made to independent software developers and/or contract engineers. The Company accounts for software development costs in accordance with the FASB guidance for the costs of computer software to be sold, leased, or otherwise marketed (“ASC Subtopic 985 20” not not Capitalized costs for those products that are cancelled or abandoned are charged to impairment expense in the period of cancellation. Commencing upon product release, capitalized software development costs are amortized to “Amortization Expense - Development” based on the straight-line method over a twenty-four The Company evaluates the future recoverability of capitalized software development costs on an annual basis. For products that have been released in prior years, the primary evaluation criterion is ongoing relations with the customer. The Company’s evaluation of its capitalized software development asset resulted in impairment charges of $0 for the year ended December 31, 2022 December 31, 2021 |
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] | Impairment of Long-Lived Assets We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not |
Foreign Currency Transactions and Translations Policy [Policy Text Block] | Foreign Currency Translation The Company translates the financial statements of its foreign subsidiary from the local (functional) currency into US Dollars using the year or reporting period end or average exchange rates in accordance with the requirements of Accounting Standards Codification subtopic 830 10, 830 10” |
Derivatives, Reporting of Derivative Activity [Policy Text Block] | Derivative Financial Instruments We do not We review the terms of the common stock, warrants and convertible debt we issue to determine whether there are embedded derivative instruments, including embedded conversion options, which are required to be bifurcated and accounted for separately as derivative financial instruments. In circumstances where the host instrument contains more than one |
Revenue [Policy Text Block] | Revenue Recognition and Concentrations Our Recurrency platform is a hosted solution. We generate revenue from licensing our software to clients in our software as a service model, per-message and per-minute transactional fees, and customized professional services. We recognize license/subscription fees over the period of the contract, service fees as the services are performed, and per-message or per-minute transaction revenue when the transaction takes place. Under Topic 606, no During the years ended December 31, 2022 2021 two |
Comprehensive Income, Policy [Policy Text Block] | Comprehensive Income (Loss) Comprehensive loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We are required to record all components of comprehensive loss in the consolidated financial statements in the period in which they are recognized. Net loss and other comprehensive loss, including foreign currency translation adjustments and unrealized gains and losses on investments, are reported, net of their related tax effect, to arrive at comprehensive loss. For the twelve December 31, 2022 2021 $10,109,997,and |
Share-Based Payment Arrangement [Policy Text Block] | Stock-based Compensation We primarily issue stock-based awards to employees in the form of stock options. We determine compensation expense associated with stock options based on the estimated grant date fair value method using the Black-Scholes valuation model. We recognize compensation expense using a straight-line amortization method over the respective vesting period. |
Research and Development Expense, Policy [Policy Text Block] | Research and Development Expenditures Research and development expenditures are expensed as incurred, and consist primarily of compensation costs, outside services, and expensed materials. |
Advertising Cost [Policy Text Block] | Advertising Expense Direct advertising costs are expensed as incurred and consist primarily of E-commerce advertisements, sales enablement, content creation, and other direct costs. Advertising expense was $377,201 and $962,049 for years ended December 31, 2022 2021 December 31, 2022 2021 |
Income Tax, Policy [Policy Text Block] | Income Taxes We account for income taxes using the assets and liability method, which recognizes deferred tax assets and liabilities determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established to reduce deferred tax assets when, based on available objective evidence, it is more likely than not not not |
Earnings Per Share, Policy [Policy Text Block] | Computation of Net Loss per Common Share Basic net loss per share is based upon the weighted average number of common shares outstanding. Diluted net loss per share is based on the assumption that all potential common stock equivalents (convertible notes payable, stock options, and warrants) are converted or exercised. The calculation of diluted net loss per share excludes potential common stock equivalents if the effect is anti-dilutive. Our weighted average common shares outstanding for basic and diluted are the same because the effect of the potential common stock equivalents is anti-dilutive. We had the following dilutive common stock equivalents as of December 31, 2022 2021 December 31, 2022 2021 Outstanding employee options 6,691,216 6,246,466 Outstanding restricted stock units 1,929,933 1,685,141 Outstanding warrants 6,147,898 3,246,690 14,769,047 11,178,297 |
New Accounting Pronouncements, Policy [Policy Text Block] | Recent Accounting Pronouncements Accounting standards promulgated by the FASB are subject to change. Changes in such standards may In August 2020, 2020 06, 2020 06” No. 2020 06 January 1, 2022. |
Note 2 - Summary of Significa_2
Note 2 - Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Notes Tables | |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] | December 31, 2022 2021 Outstanding employee options 6,691,216 6,246,466 Outstanding restricted stock units 1,929,933 1,685,141 Outstanding warrants 6,147,898 3,246,690 14,769,047 11,178,297 |
Note 4 - Goodwill and Intangi_2
Note 4 - Goodwill and Intangible Assets (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Notes Tables | |
Schedule of Goodwill [Table Text Block] | Goodwill December 31, 2020 $ 496,352 Acquired — Impairment (85,169 ) December 31, 2021 411,183 Acquired — Impairment (411,183 ) December 31, 2022 $ — |
Schedule of Finite-Lived Intangible Assets [Table Text Block] | December 31, 2022 December 31, 2021 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Useful Life (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Useful Life (Years) Patents and trademarks $ 57,595 $ (4,897 ) $ 52,698 14 $ 105,543 $ (47,948 ) $ 57,595 14 Customer and merchant relationships 545,533 (514,843 ) 30,690 10 2,321,112 (1,775,579 ) 545,533 10 Trade name 32,393 (24,343 ) 8,050 10 197,955 (165,562 ) 32,393 10 Acquired technology 112,191 (112,191 ) — 10 621,030 (508,839 ) 112,191 10 Non-compete agreement 29,212 (29,212 ) — 2 79,300 (50,088 ) 29,212 2 $ 776,924 $ (685,486 ) $ 91,438 $ 3,324,940 $ (2,548,016 ) $ 776,924 |
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] | Year ending December 31, Amount 2022 $ 35,885 2023 12,639 2024 4,891 2025 4,891 2025 4,891 Thereafter 28,241 Total $ 91,438 |
Note 5 - Software Development_2
Note 5 - Software Development Costs (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Notes Tables | |
Research Development And Computer Software Disclosure [Table Text Block] | December 31, 2022 December 31, 2021 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Useful Life (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Useful Life (Years) $ 2,578,611 $ (2,475,277 ) $ 103,334 2 $ 2,565,525 $ (2,217,729 ) $ 347,796 2 $ 2,578,611 $ (2,475,277 ) $ 103,334 $ 2,565,525 $ (2,217,729 ) $ 347,796 |
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] | Year ending December 31, Amount 2022 $ 35,885 2023 12,639 2024 4,891 2025 4,891 2025 4,891 Thereafter 28,241 Total $ 91,438 |
Computer Software, Intangible Asset [Member] | |
Notes Tables | |
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] | Year ending December 31, Amount 2023 98,828 2024 4,506 2025 — 2026 — 2027 — Thereafter — Total $ 103,334 |
Note 6 - Operating Lease Asse_2
Note 6 - Operating Lease Assets (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Notes Tables | |
Additional Details Related To Leases On Balance Sheet [Table Text Block] | Leases Classification Balance at December 31, 2022 Assets Current Operating lease assets Operating lease assets $ — Noncurrent Operating lease assets Noncurrent operating lease assets 981,896 Total lease assets $ 981,896 Liabilities Current Operating lease liabilities Operating lease liabilities $ 251,665 Noncurrent Operating lease liabilities Noncurrent operating lease liabilities $ 936,924 Total lease liabilities $ 1,188,589 |
Lessee, Operating Lease, Liability, Maturity [Table Text Block] | Year ending December 31, Amount 2023 $ 324,221 2024 330,894 2025 337,568 2026 344,241 2027 28,733 Thereafter — Total future lease payments 1,365,657 Less: imputed interest (177,068 ) Total $ 1,188,589 |
Lease, Cost [Table Text Block] | Weighted Average Remaining Lease Term (years) Operating leases 4.08 Weighted Average Discount Rate Operating leases 6.75 % |
Note 7 - Notes Payable and In_2
Note 7 - Notes Payable and Interest Expense (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Notes Tables | |
Schedule of Debt [Table Text Block] | Facility Maturity Interest Rate December 31, 2022 December 31, 2021 ACOA Note February 1, 2024 — 34,231 76,642 TD Bank December 31, 2022 — 29,478 31,496 Related Party Notes various 15 % 5,192,461 3,318,242 Total Debt 5,256,170 3,426,380 Less current portion (2,743,788 ) (888,583 ) Long-term debt, net of current portion $ 2,512,382 $ 2,537,797 |
Schedule of Maturities of Long-Term Debt [Table Text Block] | Year ending December 31, Amount 2023 $ 2,743,788 2024 2,497,643 2025 14,739 2026 — 2027 — Thereafter — Total future debt payments 5,256,170 |
Summary Of Interest Expense [Table Text Block] | December 31, 2022 2021 Interest expense $ 737,745 $ 267,966 Total interest expense $ 737,745 $ 267,966 |
Note 9 - Stock-based Plans an_2
Note 9 - Stock-based Plans and Stock-based Compensation (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Notes Tables | |
Share-Based Payment Arrangement, Option, Activity [Table Text Block] | Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding at December 31, 2020 6,007,552 $ 1.20 6.77 $ 527,868 Granted 637,500 $ 1.56 — $ — Exercised — $ 1.61 — $ — Forfeit/canceled (272,029 ) $ 2.18 — $ — Expired (126,557 ) $ 1.17 — $ — Outstanding at December 31, 2021 6,246,466 $ 1.20 7.17 $ 4,056,639 Granted 1,375,000 $ 1.02 — $ — Exercised — $ — — $ — Forfeit/canceled (330,623 ) $ 1.09 — $ — Expired (599,627 ) $ 0.98 — $ — Outstanding at December 31, 2022 6,691,216 $ 1.19 5.86 $ 2,086,829 Expected to vest at December 31, 2022 6,691,216 $ 1.19 5.85 $ 2,086,829 Exercisable at December 31, 2022 3,987,966 $ 1.22 3.98 $ 1,314,652 Unrecognized expense at December 31, 2022 $ 1,698,126 |
Share-Based Payment Arrangement, Cost by Plan [Table Text Block] | Years Ended December 31, 2022 2021 General and administrative $ 262,060 $ 289,782 Sales and marketing 113,838 81,093 Engineering, research, and development 211,712 178,893 $ 587,610 $ 549,768 |
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] | Years Ended December 31, 2022 2021 Risk-free interest rate 0.25% to 0.38% 0.42% to 0.58% Expected life (years) 7.00 6.00 Expected dividend yield — — Expected volatility 72.337% to 76.15% 77.36% to 78.21% |
Restricted Stock Units (RSUs) [Member] | |
Notes Tables | |
Share-Based Payment Arrangement, Cost by Plan [Table Text Block] | Years Ended December 31, 2022 2021 General and administrative $ 260,010 $ 260,005 Sales and Marketing — 187,501 $ 260,010 $ 447,506 |
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] | Shares Weighted Average Grant Date Fair Value Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding at December 31, 2020 1,436,728 $ 0.86 — $ 1,120,404 Awarded 654,663 $ 1.77 — $ 60,003 Released — $ — — $ — Canceled/forfeited/expired (406,250 ) $ 1.80 — $ — Outstanding at December 31, 2021 1,685,141 $ 1.18 — $ 1,180,407 Awarded 244,792 $ 1.06 — $ 260,579 Released — $ — — $ — Canceled/forfeited/expired — $ — — $ — Outstanding at December 31, 2022 1,929,933 $ 0.75 — $ 1,440,986 Vested at December 31, 2022 1,929,933 $ — — $ 1,865,401 Unvested at December 31, 2022 — $ — — $ — Unrecognized expense at December 31, 2022 $ — |
Note 10 - Warrants to Purchas_2
Note 10 - Warrants to Purchase Common Stock (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Notes Tables | |
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] | Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Outstanding at December 31, 2020 2,691,459 $ 1.99 2.94 Granted 580,231 $ — — Exercised — $ — — Canceled/forfeited/expired (25,000 ) $ — — Outstanding at December 31, 2021 3,246,690 $ 2.26 3.59 Granted 6,089,398 $ — — Exercised — $ — — Canceled/forfeited/expired (3,188,190 ) $ — — Outstanding at December 31, 2022 6,147,898 $ 1.45 2.27 |
Note 11 - Income Taxes (Tables)
Note 11 - Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Notes Tables | |
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] | 2022 2021 Federal – current $ — $ — State – current — — Foreign – current — — Total $ — $ — |
Schedule of Deferred Tax Assets and Liabilities [Table Text Block] | 2022 2021 Deferred tax assets (liabilities): Net operating loss carryforwards $ 19,791,000 $ 16,915,000 Stock based compensation 4,781,000 4,372,000 Accrued compensation 231,300 31,000 Depreciation and amortization 3,305,000 3,783,000 Other — 2,000 Total deferred tax assets 28,108,300 25,103,000 Valuation allowance for net deferred tax assets (28,108,300 ) (25,103,000 ) Total $ — $ — |
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] | 2022 2021 Computed expected tax expense $ (2,088,000 ) $ (1,735,000 ) State taxes, net of federal benefit (1,030,000 ) (799,000 ) Expiration of NOL carryforwards (684,000 ) 87,000 Other 101,000 142,000 Change in valuation allowance 3,701,000 1,729,000 Total $ ---- $ |
Note 12 - Fair Value Measurem_2
Note 12 - Fair Value Measurements of Financial Instruments (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Notes Tables | |
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] | Description Level 1 Level 2 Level 3 Gains (Losses) Goodwill (non-recurring) $ — $ — $ — $ — Intangibles, net (non-recurring) $ — $ — $ 194,772 $ — Description Level 1 Level 2 Level 3 Gains (Losses) Goodwill (non-recurring) $ — $ — $ 411,183 $ — Intangibles, net (non-recurring) $ — $ — $ 1,124,720 $ — |
Note 1 - Nature of Operations (
Note 1 - Nature of Operations (Details Textual) | 12 Months Ended |
Dec. 31, 2022 | |
Average Percent Increase In Guest Spending Using Company Platform | 13% |
Percent Of Improvement In Frequency Using Company Platform | 26% |
Minimum [Member] | |
Number of Stores | 40,000 |
Note 2 - Summary of Significa_3
Note 2 - Summary of Significant Accounting Policies (Details Textual) | 12 Months Ended | |
Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | |
Accounts Receivable, Allowance for Credit Loss, Current | $ 34,446 | $ 56,340 |
Goodwill, Impairment Loss | 411,183 | 85,169 |
Impairment of Intangible Assets (Excluding Goodwill), Total | 552,476 | 8,286 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Total | (10,109,997) | (8,288,426) |
Advertising Expense | 377,201 | 962,049 |
Marketing Expense | $ 101,044 | $ 50,267 |
Computer Software, Intangible Asset [Member] | ||
Finite-Lived Intangible Asset, Useful Life (Year) | 2 years | 2 years |
Impairment of Intangible Assets, Finite-Lived | $ 0 | $ 0 |
Minimum [Member] | ||
Finite-Lived Intangible Asset, Useful Life (Year) | 1 year | |
Maximum [Member] | ||
Finite-Lived Intangible Asset, Useful Life (Year) | 20 years | |
Accounts Receivable [Member] | Customer Concentration Risk [Member] | ||
Number of Major Customers | 4 | 3 |
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Two Customers [Member] | ||
Concentration Risk, Percentage | 86% | 94% |
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | ||
Number of Major Customers | 2 | 2 |
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Two Customers [Member] | ||
Concentration Risk, Percentage | 51% | 55% |
Note 2 - Summary of Significa_4
Note 2 - Summary of Significant Accounting Policies - Computation of Net Loss Per Common Share (Details) - shares | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Antidilutive securities (in shares) | 14,769,047 | 11,178,297 |
Share-Based Payment Arrangement, Option [Member] | ||
Antidilutive securities (in shares) | 6,691,216 | 6,246,466 |
Restricted Stock Units (RSUs) [Member] | ||
Antidilutive securities (in shares) | 1,929,933 | 1,685,141 |
Warrant [Member] | ||
Antidilutive securities (in shares) | 6,147,898 | 3,246,690 |
Note 3 - Going Concern (Details
Note 3 - Going Concern (Details Textual) - USD ($) | 1 Months Ended | 3 Months Ended | 12 Months Ended | |
Feb. 28, 2022 | Mar. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Cash | $ 426,740 | $ 735,424 | ||
Net Income (Loss) Attributable to Parent, Total | (10,061,122) | (8,259,784) | ||
Net Cash Provided by (Used in) Operating Activities, Total | (6,688,551) | (4,484,598) | ||
Proceeds from Warrant Exercises | $ 2,600,000 | |||
Proceeds from Issuance of Private Placement | 2,100,000 | |||
Retained Earnings (Accumulated Deficit), Total | $ (117,896,409) | $ (107,835,287) | ||
Subsequent Event [Member] | ||||
Proceeds from Warrant Exercises | $ 3,557,487 |
Note 4 - Goodwill and Intangi_3
Note 4 - Goodwill and Intangible Assets (Details Textual) - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Goodwill, Impairment Loss | $ 411,183 | $ 85,169 |
Amortization of Intangible Assets | 133,010 | 163,760 |
Impairment of Intangible Assets (Excluding Goodwill), Total | $ 552,476 | $ 8,286 |
Note 4 - Goodwill and Intangi_4
Note 4 - Goodwill and Intangible Assets - Schedule of Goodwill (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Goodwill | $ 411,183 | $ 496,352 |
Acquired | 0 | 0 |
Impairment | (411,183) | (85,169) |
Goodwill | $ 0 | $ 411,183 |
Note 4 - Goodwill and Intangi_5
Note 4 - Goodwill and Intangible Assets - Schedule of Finite Lived Intangible Assets (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Patents and Trademarks [Member] | ||
Gross carrying amount | $ 57,595 | $ 105,543 |
Accumulated Amortization | (4,897) | (47,948) |
Net carrying amount | $ 52,698 | $ 57,595 |
Finite-Lived Intangible Asset, Useful Life (Year) | 14 years | 14 years |
Customer Relationships [Member] | ||
Gross carrying amount | $ 545,533 | $ 2,321,112 |
Accumulated Amortization | (514,843) | (1,775,579) |
Net carrying amount | $ 30,690 | $ 545,533 |
Finite-Lived Intangible Asset, Useful Life (Year) | 10 years | 10 years |
Trade Names [Member] | ||
Gross carrying amount | $ 32,393 | $ 197,955 |
Accumulated Amortization | (24,343) | (165,562) |
Net carrying amount | $ 8,050 | $ 32,393 |
Finite-Lived Intangible Asset, Useful Life (Year) | 10 years | 10 years |
Developed Technology Rights [Member] | ||
Gross carrying amount | $ 112,191 | $ 621,030 |
Accumulated Amortization | (112,191) | (508,839) |
Net carrying amount | $ 0 | $ 112,191 |
Finite-Lived Intangible Asset, Useful Life (Year) | 10 years | 10 years |
Noncompete Agreements [Member] | ||
Gross carrying amount | $ 29,212 | $ 79,300 |
Accumulated Amortization | (29,212) | (50,088) |
Net carrying amount | $ 0 | $ 29,212 |
Finite-Lived Intangible Asset, Useful Life (Year) | 2 years | 2 years |
Intangibles Excluding Capitalized Software [Member] | ||
Gross carrying amount | $ 776,924 | $ 3,324,940 |
Accumulated Amortization | (685,486) | (2,548,016) |
Net carrying amount | $ 91,438 | $ 776,924 |
Note 4 - Goodwill and Intangi_6
Note 4 - Goodwill and Intangible Assets - Future Amortization Intangible Assets (Details) - Intangibles Excluding Capitalized Software [Member] - USD ($) | Dec. 31, 2022 | Dec. 31, 2021 |
2022 | $ 35,885 | |
2023 | 12,639 | |
2024 | 4,891 | |
2025 | 4,891 | |
2025 | 4,891 | |
Thereafter | 28,241 | |
Total | $ 91,438 | $ 776,924 |
Note 5 - Software Development_3
Note 5 - Software Development Costs (Details Textual) - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Capitalized Computer Software, Impairments | $ 13,087 | $ 299,253 |
Amortization of Intangible Assets | $ 133,010 | $ 163,760 |
Computer Software, Intangible Asset [Member] | ||
Finite-Lived Intangible Asset, Useful Life (Year) | 2 years | 2 years |
Amortization of Intangible Assets | $ 257,548 | $ 391,365 |
Impairment of Intangible Assets, Finite-Lived | $ 0 | $ 0 |
Note 5 - Software Development_4
Note 5 - Software Development Costs - Software Development Costs (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Capitalized Computer Software, Gross | $ 2,578,611 | $ 2,565,525 |
Capitalized Computer Software, Accumulated Amortization | (2,475,277) | (2,217,729) |
Capitalized Computer Software, Net, Ending Balance | 103,334 | 347,796 |
Computer Software, Intangible Asset [Member] | ||
Capitalized Computer Software, Gross | 2,578,611 | 2,565,525 |
Capitalized Computer Software, Accumulated Amortization | (2,475,277) | (2,217,729) |
Capitalized Computer Software, Net, Ending Balance | $ 103,334 | $ 347,796 |
Finite-Lived Intangible Asset, Useful Life (Year) | 2 years | 2 years |
Note 5 - Software Development_5
Note 5 - Software Development Costs - Estimated Future Amortization Expense (Details) - Computer Software, Intangible Asset [Member] | Dec. 31, 2022 USD ($) |
2022 | $ 98,828 |
2023 | 4,506 |
2024 | 0 |
2025 | 0 |
Thereafter | 0 |
Total | $ 103,334 |
Note 6 - Operating Lease Asse_3
Note 6 - Operating Lease Assets (Details Textual) | 12 Months Ended | ||
Feb. 01, 2021 USD ($) ft² | Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | |
Operating Lease, Right-of-Use Asset, Amortization Expense | $ 23,599 | $ 2,575 | |
Payments for Rent | $ 371,213 | $ 258,368 | |
Lease Ending January 2027 [Member] | |||
Area of Real Estate Property (Square Foot) | ft² | 8,898 | ||
Lease Ending January 2027 [Member] | Minimum [Member] | |||
Monthly Rental Expense | $ 25,953 | ||
Lease Ending January 2027 [Member] | Maximum [Member] | |||
Monthly Rental Expense | $ 28,733 |
Note 6 - Operating Lease Asse_4
Note 6 - Operating Lease Assets - Additional Details Related To Lease (Details) - USD ($) | Dec. 31, 2022 | Dec. 31, 2021 |
Operating lease assets | $ 0 | |
Operating lease assets | 981,896 | |
Operating lease assets | 981,896 | $ 1,187,537 |
Operating lease liability, current | 251,665 | 229,240 |
Operating lease liabilities | 936,924 | $ 1,188,589 |
Total lease liabilities | $ 1,188,589 |
Note 6 - Operating Lease Asse_5
Note 6 - Operating Lease Assets - Schedule of Minimum Lease Payments (Details) | Dec. 31, 2022 USD ($) |
2023 | $ 324,221 |
2024 | 330,894 |
2025 | 337,568 |
2026 | 344,241 |
2027 | 28,733 |
Thereafter | 0 |
Total future lease payments | 1,365,657 |
Less: imputed interest | (177,068) |
Operating Lease, Liability, Total | $ 1,188,589 |
Note 6 - Operating Lease Asse_6
Note 6 - Operating Lease Assets - Weight Average Remaining Term and Discount Rate (Details) | Dec. 31, 2022 |
Weighted Average Remaining Lease Term (years) Operating leases (Year) | 4 years 29 days |
Weighted Average Discount Rate, Operating leases | 6.75% |
Note 7 - Notes Payable and In_3
Note 7 - Notes Payable and Interest Expense (Details Textual) | 1 Months Ended | 3 Months Ended | 5 Months Ended | 6 Months Ended | 12 Months Ended | ||||||||||||||||||||||||||
Dec. 27, 2022 USD ($) | Nov. 30, 2022 USD ($) | Nov. 22, 2022 USD ($) | Aug. 09, 2022 USD ($) | Aug. 01, 2022 CAD ($) | Jun. 10, 2022 USD ($) | Aug. 01, 2021 CAD ($) | Jul. 21, 2021 USD ($) | Jul. 01, 2021 USD ($) shares | Jun. 30, 2021 USD ($) $ / shares | Apr. 22, 2020 USD ($) | Apr. 10, 2020 USD ($) | Nov. 01, 2019 CAD ($) | Nov. 14, 2018 USD ($) | Nov. 06, 2017 CAD ($) | Mar. 31, 2023 $ / shares shares | Mar. 31, 2023 USD ($) $ / shares shares | Dec. 31, 2022 USD ($) shares | Dec. 31, 2022 CAD ($) | Dec. 31, 2021 USD ($) | Dec. 31, 2022 USD ($) shares | Dec. 31, 2022 CAD ($) shares | Dec. 31, 2021 USD ($) | Dec. 31, 2021 CAD ($) | Dec. 31, 2020 USD ($) | Nov. 13, 2022 $ / shares | Nov. 11, 2022 USD ($) $ / shares | Sep. 30, 2022 USD ($) | Aug. 13, 2022 $ / shares | Feb. 09, 2022 $ / shares | Apr. 22, 2020 CAD ($) | |
Gain (Loss) on Extinguishment of Debt, Total | $ 0 | $ 891,103 | |||||||||||||||||||||||||||||
Interest Expense, Debt, Total | 737,745 | 267,966 | |||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares | $ 0.80 | ||||||||||||||||||||||||||||||
Gain (loss) on Settlement of Debt | (49,503) | $ 0 | |||||||||||||||||||||||||||||
Subsequent Event [Member] | |||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares | $ 1 | $ 1 | |||||||||||||||||||||||||||||
Conversion of Interest Payable on Related Party Debt into Common Stock [Member] | Certain Investors Officers and Directors [Member] | |||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 10,352 | ||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in shares) | shares | 9,585 | 9,585 | |||||||||||||||||||||||||||||
Conversion of Interest Payable on Related Party Debt into Common Stock [Member] | Subsequent Event [Member] | Certain Investors Officers and Directors [Member] | |||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in shares) | shares | 2,757 | ||||||||||||||||||||||||||||||
Director [Member] | Conversion of Interest Payable on Related Party Debt into Common Stock [Member] | |||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 151,398 | ||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in shares) | shares | 140,185 | 140,185 | |||||||||||||||||||||||||||||
Gain (loss) on Settlement of Debt | $ (2,259) | ||||||||||||||||||||||||||||||
Director [Member] | Conversion of Interest Payable on Related Party Debt into Common Stock [Member] | Subsequent Event [Member] | |||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in shares) | shares | 154,106 | 154,106 | |||||||||||||||||||||||||||||
Gain (loss) on Settlement of Debt | $ 44,325 | ||||||||||||||||||||||||||||||
Director [Member] | Warrants To Purchase Common Stock Under Credit Agreement [Member] | |||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares | $ 1.67 | ||||||||||||||||||||||||||||||
Warrant Exercisable Period, After Issuance Of Financing (Month) | 36 months | ||||||||||||||||||||||||||||||
Warrant Vesting Period (Year) | 3 years | ||||||||||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares | 338,708 | 338,708 | |||||||||||||||||||||||||||||
Fair Value of Warrants Issued | $ 143,039 | $ 143,039 | |||||||||||||||||||||||||||||
Acoa Note [Member] | Livelenz [Member] | |||||||||||||||||||||||||||||||
Debt Instrument, Periodic Payment, Total | $ 4,500 | $ 4,000 | $ 3,500 | $ 3,000 | $ 2,215 | $ 45,052 | $ 10,485 | ||||||||||||||||||||||||
Wintrust Loan [Member] | |||||||||||||||||||||||||||||||
Debt Instrument, Periodic Payment, Total | $ 33,333 | $ 400,000 | |||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 1,000,000 | ||||||||||||||||||||||||||||||
Debt Instrument, Term (Year) | 3 years | ||||||||||||||||||||||||||||||
Proceeds from Loan Refinance | $ 1,000,000 | ||||||||||||||||||||||||||||||
Wintrust Loan [Member] | Prime Rate [Member] | |||||||||||||||||||||||||||||||
Debt Instrument, Basis Spread on Variable Rate | 1.50% | ||||||||||||||||||||||||||||||
Chase Loan [Member] | |||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 891,103 | ||||||||||||||||||||||||||||||
Debt Instrument, Term (Year) | 2 years | ||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 1% | ||||||||||||||||||||||||||||||
Gain (Loss) on Extinguishment of Debt, Total | $ 891,103 | ||||||||||||||||||||||||||||||
TD Bank [Member] | |||||||||||||||||||||||||||||||
Debt Instrument, Periodic Payment, Total | $ 0 | ||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 40,000 | ||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 0% | ||||||||||||||||||||||||||||||
Percent of Loan Forgiven | 33% | ||||||||||||||||||||||||||||||
Percent of Loan Repaid Requirement for Forgiveness | 67% | ||||||||||||||||||||||||||||||
Credit Agreement [Member] | Director [Member] | |||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 15% | 15% | |||||||||||||||||||||||||||||
Line of Credit Facility, Maximum Borrowing Capacity | $ 6,000,000 | $ 6,000,000 | $ 6,000,000 | ||||||||||||||||||||||||||||
Proceeds from Long-Term Lines of Credit Including Interest | $ 3,478,125 | 5,173,125 | |||||||||||||||||||||||||||||
Proceeds from Long-Term Lines of Credit | $ 470,000 | $ 250,000 | $ 375,000 | $ 300,000 | $ 500,000 | 3,206,250 | |||||||||||||||||||||||||
Interest Expense, Debt, Total | 166,432 | 271,875 | |||||||||||||||||||||||||||||
Repayments of Long-Term Lines of Credit | $ 200,000 | ||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares | $ 1.67 | ||||||||||||||||||||||||||||||
Warrant Exercisable Period, After Issuance Of Financing (Month) | 36 months | ||||||||||||||||||||||||||||||
Credit Facility Fee, Numerator | 20% | ||||||||||||||||||||||||||||||
Credit Facility Fee, Denominator Measurement Period (Day) | 30 days | ||||||||||||||||||||||||||||||
Warrant Vesting Period (Year) | 3 years | ||||||||||||||||||||||||||||||
Debt Instrument, Number Of Monthly Installments | 24 | ||||||||||||||||||||||||||||||
Interest Payable | 387,918 | 387,918 | |||||||||||||||||||||||||||||
Gain (loss) on Settlement of Debt | (2,259) | ||||||||||||||||||||||||||||||
Debt Instrument, Monthly Conversion of Interest, Rate Per Share (in dollars per share) | $ / shares | $ 24 | ||||||||||||||||||||||||||||||
Credit Agreement [Member] | Director [Member] | Common Stock Issued to Settle Accrued Interest [Member] | |||||||||||||||||||||||||||||||
Share Price (in dollars per share) | $ / shares | $ 1.08 | ||||||||||||||||||||||||||||||
Unsecured Notes Issued July, 1, 2021 [Member] | Certain Investors Officers and Directors [Member] | |||||||||||||||||||||||||||||||
Interest Expense, Debt, Total | 9,651 | ||||||||||||||||||||||||||||||
Interest Payable | 55,530 | 55,530 | |||||||||||||||||||||||||||||
Gain (loss) on Settlement of Debt | (162) | ||||||||||||||||||||||||||||||
Debt Instrument, Prepayment Penalty | 2% | ||||||||||||||||||||||||||||||
Payments for Commissions | $ 0 | ||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Warrants or Options Issued (in shares) | shares | 33,017 | ||||||||||||||||||||||||||||||
Debt Instrument, Monthly Conversion of Interest, Rate Per Share (in dollars per share) | $ / shares | $ 24 | ||||||||||||||||||||||||||||||
Long-Term Debt, Gross | 271,875 | 271,875 | |||||||||||||||||||||||||||||
Unsecured Notes Issued July, 1, 2021 [Member] | Certain Investors Officers and Directors [Member] | |||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 271,875 | ||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 15% | ||||||||||||||||||||||||||||||
Interest Payable | 55,530 | 55,530 | |||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 10,352 | ||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in shares) | shares | 9,585 | 9,585 | |||||||||||||||||||||||||||||
Gain (loss) on Settlement of Debt | $ (162) | ||||||||||||||||||||||||||||||
Debt Instrument, Prepayment Penalty | 2% | ||||||||||||||||||||||||||||||
Payments for Commissions | $ 0 | ||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Warrants or Options Issued (in shares) | shares | 33,017 | ||||||||||||||||||||||||||||||
Long-Term Debt, Gross | $ 271,875 | $ 271,875 | |||||||||||||||||||||||||||||
Unsecured Notes Issued July, 1, 2021 [Member] | Certain Investors Officers and Directors [Member] | Subsequent Event [Member] | |||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in shares) | shares | 9,651 | ||||||||||||||||||||||||||||||
Gain (loss) on Settlement of Debt | $ 2,757 |
Note 7 - Notes Payable and In_4
Note 7 - Notes Payable and Interest Expense - Schedule of Notes Payable (Details) - USD ($) | Dec. 31, 2022 | Dec. 31, 2021 | Apr. 22, 2020 |
Debt and Lease Obligation, Total | $ 5,256,170 | $ 3,426,380 | |
Less current portion | (2,743,788) | (888,583) | |
Long-term debt, net of current portion | 2,512,382 | 2,537,797 | |
Acoa Note [Member] | |||
Debt and Lease Obligation, Total | 34,231 | 76,642 | |
TD Bank [Member] | |||
Debt and Lease Obligation, Total | 29,478 | 31,496 | |
Debt Instrument Interest Rate Stated Percentage | 0% | ||
Related Party Note [Member] | |||
Debt and Lease Obligation, Total | $ 5,192,461 | $ 3,318,242 | |
Debt Instrument Interest Rate Stated Percentage | 15% |
Note 7 - Notes Payable and In_5
Note 7 - Notes Payable and Interest Expense - Schedule of Maturities (Details) - USD ($) | Dec. 31, 2022 | Dec. 31, 2021 |
2023 | $ 2,743,788 | |
2024 | 2,497,643 | |
2025 | 14,739 | |
2026 | 0 | |
2027 | 0 | |
Thereafter | 0 | |
Total future debt payments | $ 5,256,170 | $ 3,426,380 |
Note 7 - Notes Payable and In_6
Note 7 - Notes Payable and Interest Expense - Summary of Interest Expense (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Interest expense | $ 737,745 | $ 267,966 |
Total interest expense | $ 737,745 | $ 267,966 |
Note 8 - Common Stock and Equ_2
Note 8 - Common Stock and Equity Payable (Details Textual) - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Share-Based Payment Arrangement, Expense | $ 1,457,570 | |
Equity Amount Payable | 324,799 | $ 100,862 |
Restricted Stock Units (RSUs) [Member] | ||
Share-Based Payment Arrangement, Expense | $ 260,010 | $ 447,506 |
Restricted Stock Units (RSUs) [Member] | Board Of Directors [Member] | ||
Stock Issued During Period, Shares, New Issues (in shares) | 5,900,460 | 0 |
Share-Based Payment Arrangement, Expense | $ 260,010 | $ 260,005 |
Restricted Stock Units (RSUs) [Member] | Employees [Member] | ||
Share-Based Payment Arrangement, Expense | $ 0 | $ 187,501 |
Note 9 - Stock-based Plans an_3
Note 9 - Stock-based Plans and Stock-based Compensation (Details Textual) | 3 Months Ended | 12 Months Ended | |||||||||||||
Dec. 31, 2022 USD ($) $ / shares shares | Dec. 14, 2022 USD ($) $ / shares shares | Sep. 30, 2022 USD ($) $ / shares shares | Sep. 22, 2022 USD ($) $ / shares shares | May 16, 2022 USD ($) $ / shares shares | Mar. 29, 2022 USD ($) $ / shares shares | Dec. 15, 2021 USD ($) $ / shares shares | Aug. 11, 2021 USD ($) $ / shares shares | May 17, 2021 USD ($) $ / shares shares | May 12, 2021 $ / shares shares | Mar. 26, 2021 USD ($) $ / shares shares | Sep. 30, 2021 USD ($) | Jun. 30, 2021 USD ($) | Dec. 31, 2022 USD ($) $ / shares shares | Dec. 31, 2021 USD ($) $ / shares shares | |
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares) | shares | 14,769,047 | 14,769,047 | |||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares) | shares | 22,585,015 | 22,585,015 | |||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year) | 36 months | 36 months | 36 months | 36 months | 48 years | 48 years | 48 years | 48 years | |||||||
Options To Purchase Shares Inthemoney (in shares) | shares | 4,057,500 | 4,057,500 | |||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares | $ 0.99 | $ 0.79 | |||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares) | shares | 180,000 | 1,000,000 | 45,000 | 150,000 | 545,000 | 5,000 | 20,000 | 67,500 | |||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares | $ 1.44 | $ 0.98 | $ 0.97 | $ 0.8289 | $ 1.53 | $ 1.53 | $ 1.67 | $ 1.80 | |||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate | 75.76% | 76.15% | 73.45% | 72.33% | 71.53% | 73.29% | 74.79% | 73.97% | |||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value (in dollars per share) | $ / shares | $ 1.039857 | $ 0.697499 | $ 0.642608 | $ 0.54 | $ 0.97 | $ 1.12 | $ 0.93 | $ 1.16 | |||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Call Option Value | $ 187,174 | $ 697,499 | $ 28,917 | $ 81,035 | $ 528,434 | $ 5,606 | $ 18,628 | $ 78,492 | |||||||
Number of Employees, Awards Granted | 1 | 1 | 3 | 1 | 19 | 1 | 1 | ||||||||
Share-Based Payment Arrangement, Expense | $ 1,457,570 | ||||||||||||||
Deferred Compensation Equity | $ 1,527,647 | $ 1,527,647 | |||||||||||||
Vesting on the First Anniversary [Member] | |||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage | 25% | 25% | 25% | 25% | |||||||||||
Share-Based Payment Arrangement, Option [Member] | |||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year) | 4 years | ||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year) | 10 years | ||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares) | shares | 1,375,000 | 637,500 | |||||||||||||
Share-Based Payment Arrangement, Expense | $ 587,610 | $ 549,768 | |||||||||||||
Restricted Stock Units (RSUs) [Member] | |||||||||||||||
Share-Based Payment Arrangement, Expense | 260,010 | 447,506 | |||||||||||||
Salary and Wage, Officer, Excluding Cost of Good and Service Sold | 260,010 | 447,506 | |||||||||||||
Restricted Stock Units (RSUs) [Member] | Employees [Member] | |||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year) | 4 years | ||||||||||||||
Share-Based Payment Arrangement, Expense | 0 | 187,501 | |||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) | shares | 500,000 | ||||||||||||||
Share-Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Grants In Period, Value | $ 900,000 | ||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Intrinsic Value, Amount Per Share (in dollars per share) | $ / shares | $ 1.80 | ||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares) | shares | 114,583 | ||||||||||||||
Restricted Stock Units (RSUs) [Member] | Board Of Directors [Member] | |||||||||||||||
Number of Employees, Awards Granted | 4 | 4 | 4 | 4 | 4 | 4 | 4 | ||||||||
Share-Based Payment Arrangement, Expense | 260,010 | $ 260,005 | |||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) | shares | 47,104 | 65,100 | 54,168 | 78,420 | 42,484 | 37,144 | 38,924 | 36,112 | |||||||
Share-Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Grants In Period, Value | $ 65,004 | $ 65,002 | $ 65,002 | $ 65,002 | $ 65,000 | $ 65,000 | $ 65,000 | $ 65,000 | |||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Intrinsic Value, Amount Per Share (in dollars per share) | $ / shares | $ 1.38 | $ 0.9985 | $ 1.20 | $ 0.829 | $ 1.53 | $ 1.75 | $ 1.67 | $ 1.80 | |||||||
Investor Warrant [Member] | |||||||||||||||
Share-Based Payment Arrangement, Expense | $ 609,950 |
Note 9 - Stock-based Plans an_4
Note 9 - Stock-based Plans and Stock-based Compensation - Stock Options Activity (Details) - USD ($) | 12 Months Ended | ||||||||||
Dec. 14, 2022 | Sep. 22, 2022 | May 16, 2022 | Mar. 29, 2022 | Dec. 15, 2021 | Aug. 11, 2021 | May 17, 2021 | Mar. 26, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Granted, shares (in shares) | 180,000 | 1,000,000 | 45,000 | 150,000 | 545,000 | 5,000 | 20,000 | 67,500 | |||
Share-Based Payment Arrangement, Option [Member] | |||||||||||
Balance (in shares) | 6,246,466 | 6,007,552 | |||||||||
Balance, exercise price (in dollars per share) | $ 1.20 | $ 1.20 | |||||||||
Balance, contractual term (Year) | 5 years 10 months 9 days | 7 years 2 months 1 day | 6 years 9 months 7 days | ||||||||
Balance, aggregate intrinsic value | $ 2,086,829 | $ 4,056,639 | $ 527,868 | ||||||||
Granted, shares (in shares) | 1,375,000 | 637,500 | |||||||||
Granted, exercise price (in dollars per share) | $ 1.02 | $ 1.56 | |||||||||
Exercised, shares (in shares) | 0 | 0 | |||||||||
Exercised, exercise price (in dollars per share) | $ 0 | $ 1.61 | |||||||||
Forfeit/canceled, shares (in shares) | (330,623) | (272,029) | |||||||||
Forfeit/canceled, exercise price (in dollars per share) | $ 1.09 | $ 2.18 | |||||||||
Expired, shares (in shares) | (599,627) | (126,557) | |||||||||
Expired, exercise price (in dollars per share) | $ 0.98 | $ 1.17 | |||||||||
Exercised, shares (in shares) | 0 | 0 | |||||||||
Balance, shares (in shares) | 6,691,216 | 6,246,466 | 6,007,552 | ||||||||
Balance, exercise price (in dollars per share) | $ 1.19 | $ 1.20 | $ 1.20 | ||||||||
Expected to vest at End of Period (in shares) | 6,691,216 | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price (in dollars per share) | $ 1.19 | ||||||||||
Expected, Weighted Average Remaining Contractual Term (Years) (Year) | 5 years 10 months 6 days | ||||||||||
Share-Based Compensation Arrangement By Share-Based Payment Award Options Vested And Expected To Vest Aggregate Intrinsic Value | $ 2,086,829 | ||||||||||
Exercisable at End of Period (in shares) | 3,987,966 | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in dollars per share) | $ 1.22 | ||||||||||
Exercisable, Weighted Average Remaining Contractual Term (Years) (Year) | 3 years 11 months 23 days | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | $ 1,314,652 | ||||||||||
Unrecognized expense at End of Period | $ 1,698,126 |
Note 9 - Stock-based Plans an_5
Note 9 - Stock-based Plans and Stock-based Compensation - Schedule of Compensation Costs by Plan (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Stock-based compensation expense | $ 1,457,570 | |
Share-Based Payment Arrangement, Option [Member] | ||
Stock-based compensation expense | 587,610 | $ 549,768 |
Share-Based Payment Arrangement, Option [Member] | General and Administrative Expense [Member] | ||
Stock-based compensation expense | 262,060 | 289,782 |
Share-Based Payment Arrangement, Option [Member] | Selling and Marketing Expense [Member] | ||
Stock-based compensation expense | 113,838 | 81,093 |
Share-Based Payment Arrangement, Option [Member] | Research and Development Expense [Member] | ||
Stock-based compensation expense | $ 211,712 | $ 178,893 |
Note 9 - Stock-based Plans an_6
Note 9 - Stock-based Plans and Stock-based Compensation - Valuation Assumptions (Details) | 12 Months Ended | |||||||||
Dec. 14, 2022 | Sep. 22, 2022 | May 16, 2022 | Mar. 29, 2022 | Dec. 15, 2021 | Aug. 11, 2021 | May 17, 2021 | Mar. 26, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Expected life (years) (Year) | 7 years | 6 years | ||||||||
Expected dividend yield | 0% | 0% | ||||||||
Expected volatility | 75.76% | 76.15% | 73.45% | 72.33% | 71.53% | 73.29% | 74.79% | 73.97% | ||
Minimum [Member] | ||||||||||
Risk-free interest rate | 0.25% | 0.42% | ||||||||
Expected volatility | 72.337% | 77.36% | ||||||||
Maximum [Member] | ||||||||||
Risk-free interest rate | 0.38% | 0.58% | ||||||||
Expected volatility | 76.15% | 78.21% |
Note 9 - Stock-based Plans an_7
Note 9 - Stock-based Plans and Stock-based Compensation - Restricted Stock Unit Activity (Details) - Restricted Stock Units (RSUs) [Member] - USD ($) | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Balance, shares (in shares) | 1,685,141 | 1,436,728 | |
Balance, exercise price (in dollars per share) | $ 1.18 | $ 0.86 | |
Balance, aggregate intrinsic value | $ 1,440,986 | $ 1,180,407 | $ 1,120,404 |
Awarded, shares (in shares) | 244,792 | 654,663 | |
Awarded, exercise price (in dollars per share) | $ 1.06 | $ 1.77 | |
Awarded, aggregate intrinsic value | $ 260,579 | $ 60,003 | |
Released, shares (in shares) | 0 | 0 | |
Canceled/forfeited/expired, shares (in shares) | 0 | (406,250) | |
Canceled/forfeited/expired, exercise price (in dollars per share) | $ 0 | $ 1.80 | |
Canceled/forfeited/expired, aggregate intrinsic value | $ 0 | $ 0 | |
Balance, shares (in shares) | 1,929,933 | 1,685,141 | |
Balance, exercise price (in dollars per share) | $ 0.75 | $ 1.18 | |
Vested, shares (in shares) | 1,929,933 | ||
Vested, exercise price (in dollars per share) | $ 0 | ||
Vested, aggregate intrinsic value | $ 1,865,401 | ||
Unvested, shares (in shares) | 0 | ||
Unrecognized expense | $ 0 |
Note 9 - Stock-based Plans an_8
Note 9 - Stock-based Plans and Stock-based Compensation - Restricted Stock Compensation Cost Allocation (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Stock-based compensation expense | $ 1,457,570 | |
Restricted Stock Units (RSUs) [Member] | ||
Stock-based compensation expense | 260,010 | $ 447,506 |
Restricted Stock Units (RSUs) [Member] | General and Administrative Expense [Member] | ||
Stock-based compensation expense | 260,010 | 260,005 |
Restricted Stock Units (RSUs) [Member] | Selling and Marketing Expense [Member] | ||
Stock-based compensation expense | $ 0 | $ 187,501 |
Note 10 - Warrants to Purchas_3
Note 10 - Warrants to Purchase Common Stock (Details Textual) | 12 Months Ended | |||||||
Aug. 24, 2022 USD ($) $ / shares shares | Jun. 29, 2022 USD ($) $ / shares shares | Feb. 09, 2022 USD ($) $ / shares shares | Aug. 11, 2021 USD ($) shares | Jun. 30, 2021 USD ($) $ / shares shares | Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | Sep. 30, 2021 $ / shares shares | |
Share-Based Payment Arrangement, Expense | $ 1,457,570 | |||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares | $ 0.80 | |||||||
Number of Warrant Holders That Exercised Warrants | 17 | |||||||
Stock Issued During Period, Shares, Warrant Exercise (in shares) | shares | 3,188,190 | |||||||
Stock Issued During Period Value, Warrant Exercise | $ 2,550,553 | |||||||
Warrant Issuance Four [Member] | ||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares | 227,994 | 238,066 | ||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares | $ 1.67 | |||||||
Warrants and Rights Outstanding | $ 119,103 | |||||||
Warrant Exercisable Period, After Issuance Of Financing (Month) | 36 months | |||||||
Warrant Issuance Four Exercise Price [Member] | ||||||||
Warrants and Rights Outstanding | $ 119,760 | |||||||
Warrant Issuance Four Volume Weighted Average Price [Member] | ||||||||
Warrants and Rights Outstanding | $ 108,234 | |||||||
Warrant Issuance Five [Member] | ||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares | 10,072 | |||||||
Warrants and Rights Outstanding | $ 5,285 | |||||||
Warrant Exercisable Period, After Issuance Of Financing (Month) | 36 years | |||||||
Warrant Issuance Three [Member] | ||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares | 2,666,459 | |||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares | $ 2.06 | |||||||
Inducement Warrant [Member] | ||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares | 3,188,190 | |||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares | $ 1.50 | $ 1.50 | $ 1.50 | |||||
Stock Issued During Period, Shares, Warrant Exercise (in shares) | shares | 1,500,000 | 1,062,500 | ||||||
Warrants and Rights Outstanding, Term (Year) | 3 years | 3 years | 3 years | |||||
Warrant Issuance [Member] | ||||||||
Share-Based Payment Arrangement, Expense | $ 609,950 | |||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares | $ 0.80 | $ 0.80 | ||||||
Stock Issued During Period, Shares, Warrant Exercise (in shares) | shares | 1,500,000 | 1,062,500 | ||||||
Stock Issued During Period Value, Warrant Exercise | $ 1,200,000 | $ 850,000 | ||||||
Warrant Issuance [Member] | ||||||||
Share-Based Payment Arrangement, Expense | $ 0 |
Note 10 - Warrants to Purchas_4
Note 10 - Warrants to Purchase Common Stock - Summary of Investor Warrant Activity (Details) - $ / shares | 12 Months Ended | ||||||||||
Dec. 14, 2022 | Sep. 22, 2022 | May 16, 2022 | Mar. 29, 2022 | Dec. 15, 2021 | Aug. 11, 2021 | May 17, 2021 | Mar. 26, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Granted, shares (in shares) | 180,000 | 1,000,000 | 45,000 | 150,000 | 545,000 | 5,000 | 20,000 | 67,500 | |||
Investor Warrant [Member] | |||||||||||
Balance (in shares) | 3,246,690 | 2,691,459 | |||||||||
Balance, exercise price (in dollars per share) | $ 2.26 | $ 1.99 | |||||||||
Balance, term (in dollars per share) | $ 2.27 | $ 3.59 | $ 2.94 | ||||||||
Granted, shares (in shares) | 6,089,398 | 580,231 | |||||||||
Granted, exercise price (in dollars per share) | $ 0 | $ 0 | |||||||||
Exercised, shares (in shares) | 0 | 0 | |||||||||
Canceled/forfeited/expired, shares (in shares) | (3,188,190) | (25,000) | |||||||||
Canceled/forfeited/expired, exercise price (in dollars per share) | $ 0 | $ 0 | |||||||||
Balance, shares (in shares) | 6,147,898 | 3,246,690 | 2,691,459 | ||||||||
Balance, exercise price (in dollars per share) | $ 1.45 | $ 2.26 | $ 1.99 |
Note 11 - Income Taxes (Details
Note 11 - Income Taxes (Details Textual) - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | $ 2,479,000 | $ 568,000 |
Operating Loss Carryforwards | 64,000,000 | |
Change in ownership limit, operating loss | 207,000 | |
Pre change net operating loss carryforward | 6,000,000 | |
Liability for Uncertainty in Income Taxes, Current | 0 | |
Income Tax Examination, Penalties and Interest Accrued, Total | 0 | |
State and Local Jurisdiction [Member] | ||
Operating Loss Carryforwards | $ 61,000,000 | |
State and Local Jurisdiction [Member] | Earliest Tax Year [Member] | ||
Open Tax Year | 2006 |
Note 11 - Income Taxes - Compon
Note 11 - Income Taxes - Components of Income Tax Expense (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Federal – current | $ 0 | $ 0 |
State – current | 0 | 0 |
Foreign – current | 0 | 0 |
Total | $ 0 | $ 0 |
Note 11 - Income Taxes - Schedu
Note 11 - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) | Dec. 31, 2022 | Dec. 31, 2021 |
Net operating loss carryforwards | $ 19,791,000 | $ 16,915,000 |
Stock based compensation | 4,781,000 | 4,372,000 |
Accrued compensation | 231,300 | 31,000 |
Tax asset depreciation and amortization | 3,305,000 | 3,783,000 |
Other tax assets | 0 | 2,000 |
Total deferred tax assets | 28,108,300 | 25,103,000 |
Valuation allowance for net deferred tax assets | (28,108,300) | (25,103,000) |
Total | $ 0 | $ 0 |
Note 11 - Income Taxes - Income
Note 11 - Income Taxes - Income Tax Reconciliation (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Computed expected tax expense | $ (2,088,000) | $ (1,735,000) |
State taxes, net of federal benefit | (1,030,000) | (799,000) |
Expiration of NOL carryforwards | (684,000) | 87,000 |
Other | 101,000 | 142,000 |
Change in valuation allowance | $ 3,701,000 | $ 1,729,000 |
Note 12 - Fair Value Measurem_3
Note 12 - Fair Value Measurements of Financial Instruments- Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - Fair Value, Nonrecurring [Member] - USD ($) | Dec. 31, 2022 | Dec. 31, 2021 |
Fair Value, Inputs, Level 1 [Member] | ||
Goodwill (non-recurring) | $ 0 | $ 0 |
Intangibles, net (non-recurring) | 0 | 0 |
Fair Value, Inputs, Level 2 [Member] | ||
Goodwill (non-recurring) | 0 | 0 |
Intangibles, net (non-recurring) | 0 | 0 |
Fair Value, Inputs, Level 3 [Member] | ||
Goodwill (non-recurring) | 0 | 411,183 |
Intangibles, net (non-recurring) | $ 194,772 | $ 1,124,720 |
Note 13 - Commitments and Con_2
Note 13 - Commitments and Contingencies (Details Textual) | 12 Months Ended | |||
Apr. 01, 2022 USD ($) ft² | Feb. 01, 2021 USD ($) ft² | Dec. 31, 2022 USD ($) ft² | Dec. 31, 2021 USD ($) | |
Loss Contingency, Claims Settled, Number | 3 | |||
Gain (Loss) Related to Litigation Settlement | $ (53,500) | |||
Operating Lease, Right-of-Use Asset | 981,896 | $ 1,187,537 | ||
Operating Lease, Liability, Total | $ 1,188,589 | |||
Lease Ending January 2021 [Member] | ||||
Area of Real Estate Property (Square Foot) | ft² | 10,395 | |||
Monthly Rental Expense | $ 20,140 | |||
Operating Lease, Right-of-Use Asset | 0 | |||
Operating Lease, Liability, Total | 0 | |||
Lease Ending January 2027 [Member] | ||||
Area of Real Estate Property (Square Foot) | ft² | 8,898 | |||
Operating Lease, Right-of-Use Asset | 1,177,094 | |||
Operating Lease, Liability, Total | 1,404,533 | |||
Lessee, Operating Lease, Abatement Percentage | 50% | |||
Lease Ending January 2027 [Member] | Minimum [Member] | ||||
Monthly Rental Expense | $ 25,953 | |||
Lease Ending January 2027 [Member] | Maximum [Member] | ||||
Monthly Rental Expense | $ 28,733 | |||
Lease Ending April 2022 [Member] | ||||
Monthly Rental Expense | $ 3,371 | |||
Operating Lease, Right-of-Use Asset | 10,443 | |||
Operating Lease, Liability, Total | $ 13,296 | |||
Lease area of office (Square Foot) | ft² | 3,248 |
Note 14 - Employee Benefit Pl_2
Note 14 - Employee Benefit Plan (Details Textual) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Defined Contribution Plan, Employer Discretionary Contribution Amount | $ 0 | $ 0 |
Note 15 - Related Party Trans_2
Note 15 - Related Party Transactions (Details Textual) - USD ($) | 1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||||||||||||||||
Dec. 27, 2022 | Nov. 30, 2022 | Nov. 22, 2022 | Aug. 24, 2022 | Aug. 09, 2022 | Jun. 10, 2022 | Feb. 07, 2022 | Jul. 01, 2021 | Jun. 30, 2021 | Mar. 31, 2023 | Feb. 28, 2022 | Mar. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Nov. 13, 2022 | Nov. 11, 2022 | Sep. 30, 2022 | Jun. 29, 2022 | Feb. 09, 2022 | |
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ 0.80 | ||||||||||||||||||||
Gain (loss) on Settlement of Debt | $ (49,503) | $ 0 | |||||||||||||||||||
Interest Expense, Total | 737,745 | 267,966 | |||||||||||||||||||
Proceeds from Warrant Exercises | $ 2,600,000 | ||||||||||||||||||||
Proceeds from Issuance of Common Stock | 2,050,000 | 0 | |||||||||||||||||||
Former Director [Member] | |||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in shares) | 625,000 | ||||||||||||||||||||
Shares Issued, Price Per Share (in dollars per share) | $ 0.80 | ||||||||||||||||||||
Proceeds from Issuance of Common Stock | $ 500,000 | ||||||||||||||||||||
Subsequent Event [Member] | |||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ 1 | $ 1 | |||||||||||||||||||
Proceeds from Warrant Exercises | $ 3,557,487 | ||||||||||||||||||||
Inducement Warrant [Member] | |||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ 1.50 | $ 1.50 | $ 1.50 | ||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | 3,188,190 | ||||||||||||||||||||
Warrants and Rights Outstanding, Term (Year) | 3 years | 3 years | 3 years | ||||||||||||||||||
Inducement Warrant [Member] | Subsequent Event [Member] | |||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ 2 | $ 2 | |||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | 1,793,745 | 1,793,745 | |||||||||||||||||||
Warrants and Rights Outstanding, Term (Year) | 3 years | 3 years | |||||||||||||||||||
Warrant to Former Director [Member] | |||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ 1.50 | ||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | 625,000 | ||||||||||||||||||||
Warrants and Rights Outstanding, Term (Year) | 3 years | ||||||||||||||||||||
Director [Member] | Conversion of Interest Payable on Related Party Debt into Common Stock [Member] | |||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 151,398 | ||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in shares) | 140,185 | ||||||||||||||||||||
Gain (loss) on Settlement of Debt | $ (2,259) | ||||||||||||||||||||
Interest Expense, Total | $ 166,432 | ||||||||||||||||||||
Director [Member] | Conversion of Interest Payable on Related Party Debt into Common Stock [Member] | Subsequent Event [Member] | |||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in shares) | 154,106 | 154,106 | |||||||||||||||||||
Gain (loss) on Settlement of Debt | $ 44,325 | ||||||||||||||||||||
Director [Member] | Warrants To Purchase Common Stock Under Credit Agreement [Member] | |||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ 1.67 | ||||||||||||||||||||
Warrant Exercisable Period, After Issuance Of Financing (Month) | 36 months | ||||||||||||||||||||
Warrant Vesting Period (Year) | 3 years | ||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | 338,708 | 338,708 | |||||||||||||||||||
Warrants and Rights Outstanding | $ 143,039 | $ 143,039 | |||||||||||||||||||
Director [Member] | Common Stock Purchase Warrants [Member] | |||||||||||||||||||||
Class of Warrant or Right, Exercised During Period (in shares) | 1,604,389 | ||||||||||||||||||||
Class of Warrant or Right, Exercised During Period, Exercise Price (in dollars per share) | $ 0.80 | ||||||||||||||||||||
Proceeds from Warrant Exercises | $ 1,283,518 | ||||||||||||||||||||
Director [Member] | Inducement Warrant [Member] | |||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ 1.50 | ||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | 1,604,398 | ||||||||||||||||||||
Warrants and Rights Outstanding, Term (Year) | 3 years | ||||||||||||||||||||
Director [Member] | Credit Agreement [Member] | |||||||||||||||||||||
Line of Credit Facility, Maximum Borrowing Capacity | $ 6,000,000 | $ 6,000,000 | $ 6,000,000 | ||||||||||||||||||
Long-Term Line of Credit, Total | $ 3,478,125 | $ 3,478,125 | |||||||||||||||||||
Proceeds from Long-Term Lines of Credit | $ 470,000 | $ 250,000 | $ 375,000 | $ 300,000 | $ 500,000 | 3,206,250 | |||||||||||||||
Line Of Credit Facility, Increase From Conversion Of Notes Payable | 271,875 | ||||||||||||||||||||
Repayments of Long-Term Lines of Credit | 200,000 | ||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 15% | 15% | |||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ 1.67 | ||||||||||||||||||||
Warrant Exercisable Period, After Issuance Of Financing (Month) | 36 months | ||||||||||||||||||||
Credit Facility Fee, Numerator | 20% | ||||||||||||||||||||
Credit Facility Fee, Denominator Measurement Period (Day) | 30 days | ||||||||||||||||||||
Warrant Vesting Period (Year) | 3 years | ||||||||||||||||||||
Debt Instrument, Number Of Monthly Installments | 24 | ||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price (in dollars per share) | $ 1.08 | ||||||||||||||||||||
Proceeds from Long-Term Lines of Credit Including Interest | $ 3,478,125 | 5,173,125 | |||||||||||||||||||
Interest Payable | 387,918 | 387,918 | |||||||||||||||||||
Gain (loss) on Settlement of Debt | (2,259) | ||||||||||||||||||||
Debt Instrument, Monthly Conversion of Interest, Rate Per Share (in dollars per share) | $ 24 | ||||||||||||||||||||
Certain Investors Officers and Directors [Member] | Unsecured Notes Issued July, 1, 2021 [Member] | |||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 15% | ||||||||||||||||||||
Interest Payable | 55,530 | 55,530 | |||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 10,352 | ||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in shares) | 9,585 | ||||||||||||||||||||
Gain (loss) on Settlement of Debt | $ (162) | ||||||||||||||||||||
Interest Expense, Total | 10,423 | ||||||||||||||||||||
Debt Instrument, Face Amount | $ 271,875 | ||||||||||||||||||||
Debt Instrument, Prepayment Penalty | 2% | ||||||||||||||||||||
Payments for Commissions | $ 0 | ||||||||||||||||||||
Debt Conversion, Converted Instrument, Warrants or Options Issued (in shares) | 33,017 | ||||||||||||||||||||
Long-Term Debt, Gross | $ 271,875 | $ 271,875 | |||||||||||||||||||
Certain Investors Officers and Directors [Member] | Unsecured Notes Issued July, 1, 2021 [Member] | Subsequent Event [Member] | |||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in shares) | 9,651 | ||||||||||||||||||||
Gain (loss) on Settlement of Debt | $ 2,757 | ||||||||||||||||||||
Talkot Fund LP [Member] | Common Stock Purchase Warrants [Member] | |||||||||||||||||||||
Class of Warrant or Right, Exercised During Period (in shares) | 517,292 | ||||||||||||||||||||
Class of Warrant or Right, Exercised During Period, Exercise Price (in dollars per share) | $ 0.80 | ||||||||||||||||||||
Proceeds from Warrant Exercises | $ 413,834 | ||||||||||||||||||||
Talkot Fund LP [Member] | Inducement Warrant [Member] | |||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ 1.50 | ||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | 517,292 | ||||||||||||||||||||
Warrants and Rights Outstanding, Term (Year) | 3 years |
Note 16 - Subsequent Events (De
Note 16 - Subsequent Events (Details Textual) - USD ($) | 1 Months Ended | 3 Months Ended | ||||||
Mar. 27, 2023 | Jan. 31, 2023 | Aug. 24, 2022 | Jun. 29, 2022 | Feb. 09, 2022 | Feb. 28, 2022 | Mar. 31, 2023 | Feb. 07, 2022 | |
Stock Issued During Period, Shares, Warrant Exercise (in shares) | 3,188,190 | |||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ 0.80 | |||||||
Proceeds from Warrant Exercises | $ 2,600,000 | |||||||
Inducement Warrant [Member] | ||||||||
Stock Issued During Period, Shares, Warrant Exercise (in shares) | 1,500,000 | 1,062,500 | ||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ 1.50 | $ 1.50 | $ 1.50 | |||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | 3,188,190 | |||||||
Warrants and Rights Outstanding, Term (Year) | 3 years | 3 years | 3 years | |||||
Inducement Warrant [Member] | Director [Member] | ||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ 1.50 | |||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | 1,604,398 | |||||||
Warrants and Rights Outstanding, Term (Year) | 3 years | |||||||
Inducement Warrant [Member] | Talkot Fund LP [Member] | ||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ 1.50 | |||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | 517,292 | |||||||
Warrants and Rights Outstanding, Term (Year) | 3 years | |||||||
Subsequent Event [Member] | ||||||||
Stock Issued During Period, Shares, Warrant Exercise (in shares) | 3,587,487 | |||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ 1 | |||||||
Proceeds from Warrant Exercises | $ 3,557,487 | |||||||
Subsequent Event [Member] | Conversion of Interest Payable on Related Party Debt into Common Stock [Member] | Director [Member] | ||||||||
Stock Issued During Period, Shares, Conversion of Convertible Securities (in shares) | 154,106 | |||||||
Subsequent Event [Member] | Conversion of Interest Payable on Related Party Debt into Common Stock [Member] | Talkot Fund LP [Member] | ||||||||
Stock Issued During Period, Shares, Conversion of Convertible Securities (in shares) | 9,651 | |||||||
Subsequent Event [Member] | Former Director [Member] | ||||||||
Stock Issued During Period, Shares, Issued for Services (in shares) | 545,012 | |||||||
Subsequent Event [Member] | Inducement Warrant [Member] | ||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ 2 | |||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | 1,793,745 | |||||||
Warrants and Rights Outstanding, Term (Year) | 3 years |